<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.pharmaceutical-business-review.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c548cvistagen_and_capsant_sign_stem_cell_technology_commercialization_agre/</loc>
		<lastmod>2018-07-04T15:10:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/154bacurexo_technology_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:10:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a348ehealth_leaders_welcome_g8_infectious_disease_/</loc>
		<lastmod>2018-07-04T15:10:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca49ejavelin_and_therabel_form_partnership_for_pain/</loc>
		<lastmod>2018-07-04T15:10:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/594b6gene_express_signs_distribution_agreement_with_funa/</loc>
		<lastmod>2018-07-04T15:10:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/694b5man_pleads_guilty_to_counterfeit_impotence_drugs_off/</loc>
		<lastmod>2018-07-04T15:10:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/18489sanofiaventis_wins_rights_to_taiho_cancer/</loc>
		<lastmod>2018-07-04T15:10:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b4a4group_health_study_confirms_obesitydepression/</loc>
		<lastmod>2018-07-04T15:10:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d49atristar_to_acquire_ly/</loc>
		<lastmod>2018-07-04T15:10:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genzyme_and_isis_initiate_new_clinical_studies_of_cholesterol_drug_160109/</loc>
		<lastmod>2018-07-04T15:10:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gtcs_human_antithrombin_product_wins_positive_recommendation_from_fda_panel_160109/</loc>
		<lastmod>2018-07-04T15:10:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hgss_partner_novartis_initiates_phase_iib_hepatitis_trial_160109/</loc>
		<lastmod>2018-07-04T15:10:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/964a0novel_gene_therapy_may_help_treat_hemophi/</loc>
		<lastmod>2018-07-04T15:10:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b4b7benadryl_doesnt_help_young_children_sleep_study_/</loc>
		<lastmod>2018-07-04T15:10:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6a494ucb_boasts_of_new_regulatory_milestone_for_k/</loc>
		<lastmod>2018-07-04T15:10:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/idenix_initiates_proof_of_concept_study_for_hepatitis_drug_160109/</loc>
		<lastmod>2018-07-04T15:10:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/illumina_and_oxford_nanopore_sign_commercialization_agreement_160109/</loc>
		<lastmod>2018-07-04T15:10:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/integra_lifesciences_introduces_new_spinal_implants_160109/</loc>
		<lastmod>2018-07-04T15:10:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jennerex_and_green_cross_initiate_treatment_in_phase_ii_liver_cancer_trial_160109/</loc>
		<lastmod>2018-07-04T15:10:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/12494university_researchers_developing_multiuse_drug_/</loc>
		<lastmod>2018-07-04T15:10:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c24a8dendreon_boosted_by_provenge_trial_su/</loc>
		<lastmod>2018-07-04T15:10:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9d4bcfda_approves_genentechs_luc/</loc>
		<lastmod>2018-07-04T15:10:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lexicon_initiates_phase_ii_irritable_bowel_syndrome_trial_160109/</loc>
		<lastmod>2018-07-04T15:10:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medimetriks_introduces_three_new_topical_prescription_brands_160109/</loc>
		<lastmod>2018-07-04T15:10:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medtronic_to_acquire_ablation_frontiers_160109/</loc>
		<lastmod>2018-07-04T15:10:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/micromet_signs_licensing_agreement_with_bayer_schering_pharma_160109/</loc>
		<lastmod>2018-07-04T15:10:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/protox_initiates_phase_ii_benign_prostatic_hyperplasia_study_160109/</loc>
		<lastmod>2018-07-04T15:10:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6f496nsaids_may_not_reduce_colorectal_cancer_risk_in_sm/</loc>
		<lastmod>2018-07-04T15:10:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aa4b2antihistamine_identified_as_potential_antimal/</loc>
		<lastmod>2018-07-04T15:10:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/364a1new_study_supports_diabetesinfection/</loc>
		<lastmod>2018-07-04T15:10:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/the_medicines_company_to_acquire_targanta_therapeutics_160109/</loc>
		<lastmod>2018-07-04T15:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uk_court_validates_edwards_lifesciencess_transcatheter_valve_patent_160109/</loc>
		<lastmod>2018-07-04T15:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wyeth_and_santaris_form_alliance_to_develop_rna_based_medicines_160109/</loc>
		<lastmod>2018-07-04T15:11:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alnylam_and_cubist_form_rd_collaboration_160109/</loc>
		<lastmod>2018-07-04T15:11:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ams_wins_fda_clearance_for_new_elevate_anterior_prolapse_repair_system_160109/</loc>
		<lastmod>2018-07-04T15:11:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b04a3novartis_clozaril_has_serious_health_consequences_researcher/</loc>
		<lastmod>2018-07-04T15:11:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ark_therapeutics_wins_approval_to_initiate_phase_iii_renal_disease_study_160109/</loc>
		<lastmod>2018-07-04T15:11:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eyegate_pharmas_new_eye_drug_wins_fda_orphan_drug_designation_160109/</loc>
		<lastmod>2018-07-04T15:11:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cancer_detection_reports_q2_fiscal_2009_090116/</loc>
		<lastmod>2018-07-04T15:11:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/galapagos_forms_research_alliance_with_merck_160109/</loc>
		<lastmod>2018-07-04T15:11:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mindray_plans_to_launch_seven_to_nine_new_products_in_2009_090116/</loc>
		<lastmod>2018-07-04T15:11:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/obama_wants_congress_to_allow_federal_funding_for_stem_cell_research_090116/</loc>
		<lastmod>2018-07-04T15:11:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f24abadhezion_biomedical_wins_ce_mark_for_floraseal_microbial_se/</loc>
		<lastmod>2018-07-04T15:11:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cf4b2medicago_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:11:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/994a6roxane_laboratories_launches_epilepsy/</loc>
		<lastmod>2018-07-04T15:11:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eb49binvatec_launches_new_inpact_balloon_cat/</loc>
		<lastmod>2018-07-04T15:11:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d482scarguard_labs_appoints_ne/</loc>
		<lastmod>2018-07-04T15:11:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1f4a3paladin_and_mission_pharmacal_sign_distribution_agre/</loc>
		<lastmod>2018-07-04T15:11:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c483amarillo_to_relocate_company_to_junction_city_k/</loc>
		<lastmod>2018-07-04T15:11:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/454a6valeant_pharmaceuticals_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:11:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e5497royal_philips_and_hansen_medical_sign_cooperation_agree/</loc>
		<lastmod>2018-07-04T15:11:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/174a3celera_names_new_vice_president_of_sales_for_berkeley_heartlab_subsi/</loc>
		<lastmod>2018-07-04T15:11:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lynparza-significantly-delays-disease-progression-in-phase-iii-trial-for-ovarian-cancer-280618-6223648/</loc>
		<lastmod>2018-07-04T15:11:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-array-biopharmas-braftovimektovi-melanoma-combo-treatment-280618-6223439/</loc>
		<lastmod>2018-07-04T15:11:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/244a0clarient_launches_new_prostate_cancer/</loc>
		<lastmod>2018-07-04T15:11:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d4a6vical_wins_new_patent_for_genebased_interferon/</loc>
		<lastmod>2018-07-04T15:11:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4a48bpfizer_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:11:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/184b9galapagos_achieves_multiple_milestones_under_alliance_with_ja/</loc>
		<lastmod>2018-07-04T15:11:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizers-ibrance-breast-cancer-drug-combination-fails-to-improve-os-in-phase-3-trial-260618-6220139/</loc>
		<lastmod>2018-07-04T15:11:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/de4acbeactica_signs_research_agreement_with_ge_healthcare_and_uppsala_unive/</loc>
		<lastmod>2018-07-04T15:11:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/464a4ldr_wins_chinese_approval_for_mobic_cervical_artificial/</loc>
		<lastmod>2018-07-04T15:11:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medegen_wins_fda_clearance_for_maxguard_antimicrobial_device_150109/</loc>
		<lastmod>2018-07-04T15:11:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arcus-infinity-to-jointly-evaluate-triple-combination-cancer-therapies-270618-6221941/</loc>
		<lastmod>2018-07-04T15:11:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chmp-likely-to-recommend-approval-of-pumas-breast-cancer-drug-neratinib-270618-6221770/</loc>
		<lastmod>2018-07-04T15:11:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_obtains_second_fda_complete_response_letter_for_cancer_drug_150109/</loc>
		<lastmod>2018-07-04T15:11:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/orexigen_reports_promising_results_from_first_phase_iii_obesity_study_150109/</loc>
		<lastmod>2018-07-04T15:11:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-achaogens-zemdri-to-treat-adults-with-complicated-urinary-tract-infections-270618-6222216/</loc>
		<lastmod>2018-07-04T15:11:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/paions_sedative_meets_target_profile_in_phase_i_proof_of_concept_study_150109/</loc>
		<lastmod>2018-07-04T15:11:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regenerx_reports_encouraging_results_from_phase_ii_ulcer_trial_150109/</loc>
		<lastmod>2018-07-04T15:11:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sequenom_proposes_to_acquire_exact_sciences_for_41_million_150109/</loc>
		<lastmod>2018-07-04T15:11:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/the-dementia-discovery-fund-raises-350m-260618-6220151/</loc>
		<lastmod>2018-07-04T15:11:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thrombogenics_initiates_phase_iii_vitreomacular_adhesion_trials_150109/</loc>
		<lastmod>2018-07-04T15:11:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ucb_and_wilex_partner_to_develop_cancer_drugs_150109/</loc>
		<lastmod>2018-07-04T15:11:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-greenwichs-marijuana-based-drug-for-certain-types-of-epilepsy-260618-6219846/</loc>
		<lastmod>2018-07-04T15:11:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ertytech-confirms-focus-of-eryaspase-on-solid-tumors-and-ceases-development-in-acute-lymphoblastic-leukemia-250618-6218532/</loc>
		<lastmod>2018-07-04T15:11:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wuxi-harbour-biomed-enter-into-partnership-for-hcab-antibody-250618-6218413/</loc>
		<lastmod>2018-07-04T15:11:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vicor_wins_eurasian_patent_for_its_physiology_drug_development_platform_150109/</loc>
		<lastmod>2018-07-04T15:11:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/collegium_wins_fda_approval_for_allergic_rhinitis_drug_150109/</loc>
		<lastmod>2018-07-04T15:11:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quark_initiates_dosing_in_phase_iii_kidney_transplant_study_150109/</loc>
		<lastmod>2018-07-04T15:11:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/stellar_signs_licensing_agreement_with_eurocept_150109/</loc>
		<lastmod>2018-07-04T15:11:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sucampo_completes_enrollment_in_phase_ii_ulcer_trial_150109/</loc>
		<lastmod>2018-07-04T15:11:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synairgen-reports-positive-safety-data-for-sng001-in-phase-2-copd-trial-250618-6218219/</loc>
		<lastmod>2018-07-04T15:11:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-to-build-biologicals-development-center-in-germany-250618-6218657/</loc>
		<lastmod>2018-07-04T15:11:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ironwood-pharmaceuticals-starts-phase-iii-program-for-iw-3718-in-persistent-gastroesophageal-reflux-disease-220618-6216520/</loc>
		<lastmod>2018-07-04T15:11:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tekmira_to_receive_112_million_from_alnylam_130109/</loc>
		<lastmod>2018-07-04T15:11:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/monogram_reports_preliminary_2008_results_090115/</loc>
		<lastmod>2018-07-04T15:11:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/topigen_reports_results_from_phase_ii_asthma_trial_150109/</loc>
		<lastmod>2018-07-04T15:11:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zetiq_completes_first_arm_of_cervical_cancer_study_150109/</loc>
		<lastmod>2018-07-04T15:11:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adorx-raises-10m-funding-for-discovery-of-new-cancer-therapeutics-220618-6216370/</loc>
		<lastmod>2018-07-04T15:11:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/meridian_bioscience_reports_preliminary_q1_fiscal_2009_results_090115/</loc>
		<lastmod>2018-07-04T15:11:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shires-hae-drug-cinryze-secures-pediatric-label-expansion-in-us-220618-6216240/</loc>
		<lastmod>2018-07-04T15:11:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/new-drug-cuts-hearing-loss-in-children-by-50-after-cancer-treatment-6218991/</loc>
		<lastmod>2018-07-04T15:11:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/334a3bioe_wins_fda_clearance_for_cord_blood_processing_s/</loc>
		<lastmod>2018-07-04T15:11:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/074bckendle_establishes_new_office_in_/</loc>
		<lastmod>2018-07-04T15:11:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a44b7nanovector_names_new_vice_president_o/</loc>
		<lastmod>2018-07-04T15:11:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/88481quantrx_wins_fda_approval_for_rapidsense_phencyclidine/</loc>
		<lastmod>2018-07-04T15:11:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7b4a6st_jude_medical_wins_japanese_approval_for_atlas_i/</loc>
		<lastmod>2018-07-04T15:11:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/new-research-predicts-increased-global-demand-for-smart-pills-210618-6214243/</loc>
		<lastmod>2018-07-04T15:11:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novacap-to-acquire-us-based-cdmo-pci-synthesis-210618-6214268/</loc>
		<lastmod>2018-07-04T15:11:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novo-nordisks-semaglutide-succeeds-in-two-phase-3a-type-2-diabetes-trials-210618-6214101/</loc>
		<lastmod>2018-07-04T15:11:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b4bcgenta_initiates_new_cancer_/</loc>
		<lastmod>2018-07-04T15:11:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f94b0effrx_signs_licensing_agreement_with_ny/</loc>
		<lastmod>2018-07-04T15:11:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/014bdforest_and_cypress_win_fda_approval_fibromyalgia/</loc>
		<lastmod>2018-07-04T15:11:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/decibel-therapeutics-secures-55m-in-new-funding-round-200618-6212439/</loc>
		<lastmod>2018-07-04T15:11:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/can-fite-says-phase-2-trial-of-liver-cancer-drug-namodenoson-delayed-200618-6212228/</loc>
		<lastmod>2018-07-04T15:11:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7f48adiamedica_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:11:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uk-government-announces-56m-innovation-centre-for-scotland-190618-6210719/</loc>
		<lastmod>2018-07-04T15:11:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neurovive-grants-lhon-therapy-license-to-bridgebio-pharma-190618-6210577/</loc>
		<lastmod>2018-07-04T15:11:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunogen-gets-fda-fast-track-designation-for-mirvetuximab-soravtansine-to-treat-platinum-resistant-ovarian-cancer-190618-6210730/</loc>
		<lastmod>2018-07-04T15:11:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perkinelmer_signs_instrumentation_technologies_contract_with_intertek_090115/</loc>
		<lastmod>2018-07-04T15:11:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/52480ppd_and_whiscon_form_all/</loc>
		<lastmod>2018-07-04T15:11:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/25495antisoma_starts_phase_iii_lung_cancer_/</loc>
		<lastmod>2018-07-04T15:11:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5b484orthomimetics_obtains_ce_mark_approval_for_chondromimetic_im/</loc>
		<lastmod>2018-07-04T15:11:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/334bfnymox_reports_positive_results_from_benign_prostatic_hyperplasia_/</loc>
		<lastmod>2018-07-04T15:11:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec-to-integrate-sanofis-infectious-disease-unit-190618-6210443/</loc>
		<lastmod>2018-07-04T15:11:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/de4adjubilant_and_bioleap_form_new_drug_discovery_partne/</loc>
		<lastmod>2018-07-04T15:11:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c24aenektar_initiates_dosing_in_phase_ii_ovarian_cancer_/</loc>
		<lastmod>2018-07-04T15:11:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aa4a2abbott_introduces_new_hpv_infection_test_in_e/</loc>
		<lastmod>2018-07-04T15:11:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/whim-syndrome-treatment-x4p-001-rd-shows-significant-effect-in-phase-2-study-180618-6209232/</loc>
		<lastmod>2018-07-04T15:11:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ae48dakela_wins_e25_million_milestone_payment_from_janssen_pharmace/</loc>
		<lastmod>2018-07-04T15:11:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celltrion-resubmits-bla-with-fda-for-proposed-trastuzumab-biosimilar-180618-6208919/</loc>
		<lastmod>2018-07-04T15:11:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c54b2jazz_pharmaceuticals_completes_enrollment_in_phase_iii_fibromyalgia_/</loc>
		<lastmod>2018-07-04T15:11:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bms-elotuzumab-pomalidomide-improves-progression-free-survival-in-cancer-trial-180618-6209117/</loc>
		<lastmod>2018-07-04T15:11:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f74b7burnham_signs_assay_development_and_licensing_agreement_with_j/</loc>
		<lastmod>2018-07-04T15:11:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/854aepra_international_lsk_global_pharma_services_and_mediscience_form_partne/</loc>
		<lastmod>2018-07-04T15:11:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/57494scheringplough_licenses_symyxs_electronic_lab_not/</loc>
		<lastmod>2018-07-04T15:11:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/futility-forces-teva-to-drop-fremanezumabs-chronic-cluster-headache-study-180618-6208840/</loc>
		<lastmod>2018-07-04T15:11:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/farons-frds-treatment-traumakine-fails-to-produce-consistent-interferon-beta-bioactivity-in-phase-iii-trial-150618-6207536/</loc>
		<lastmod>2018-07-04T15:11:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cd4bcneurobiological_technologies_suspends_stroke_drug_develo/</loc>
		<lastmod>2018-07-04T15:11:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/154bbjennerex_names_new_vice_president_of_corporate_develo/</loc>
		<lastmod>2018-07-04T15:11:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sage-shionogi-to-collaborate-for-mdd-drug-in-select-asian-countries-150618-6207262/</loc>
		<lastmod>2018-07-04T15:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viivs-dolutegravirlamivudine-succeeds-in-two-phase-3-hiv-1-trials-150618-6207048/</loc>
		<lastmod>2018-07-04T15:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/recipharm-agrees-to-acquire-sanofi-cmo-business-in-uk-140618-6205690/</loc>
		<lastmod>2018-07-04T15:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/79485pluristem_files_ind_application_to_begin_phase_i_critical_limb_ischemia_/</loc>
		<lastmod>2018-07-04T15:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/11487profibrix_concludes_licensing_agreement_with_cr/</loc>
		<lastmod>2018-07-04T15:12:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_builds_manufacturing_facility_for_pandemic_flu_vaccine_090115/</loc>
		<lastmod>2018-07-04T15:12:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dxs_appoints_sales_and_marketing_director_for_north_america_090115/</loc>
		<lastmod>2018-07-04T15:12:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomerica_reports_q2_fiscal_2009_results_090114/</loc>
		<lastmod>2018-07-04T15:12:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-expands-approval-of-roches-avastin-to-cover-advanced-ovarian-cancer-140618-6205378/</loc>
		<lastmod>2018-07-04T15:12:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/flex-pharma-to-end-two-neuromuscular-disease-trials-over-safety-concerns-140618-6205235/</loc>
		<lastmod>2018-07-04T15:12:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/albireo-pharma-gets-fda-rare-pediatric-disease-designation-for-rare-liver-disease-treatment-a4250-130618-6203835/</loc>
		<lastmod>2018-07-04T15:12:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celera_appoints_vp_sales_at_bhl_090114/</loc>
		<lastmod>2018-07-04T15:12:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d9493merck_serono_and_apitope_sign_rd_agre/</loc>
		<lastmod>2018-07-04T15:12:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/09483macuclear_and_mystic_pharmaceuticals_announce_collabor/</loc>
		<lastmod>2018-07-04T15:12:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/01494santaruss_partner_receives_complete_response_letter_for_heartburn/</loc>
		<lastmod>2018-07-04T15:12:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d249acephalon_to_acquire_ception_therape/</loc>
		<lastmod>2018-07-04T15:12:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/grnenthal-begins-phase-iii-trials-in-complex-regional-pain-syndrome-130618-6203842/</loc>
		<lastmod>2018-07-04T15:12:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ascletis-ganovo-gets-chinese-approval-for-treatment-of-viral-hepatitis-c-130618-6203662/</loc>
		<lastmod>2018-07-04T15:12:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mercks-keytruda-secures-fda-approval-for-advanced-cervical-cancer-130618-6203461/</loc>
		<lastmod>2018-07-04T15:12:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1c487sr_communications_partners_with_ovation_to_launch_huntingtons/</loc>
		<lastmod>2018-07-04T15:12:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b484cumberland_names_new_product_dir/</loc>
		<lastmod>2018-07-04T15:12:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9649eangiodynamics_buys_flowmedicas_benephit_renal_therapy_product/</loc>
		<lastmod>2018-07-04T15:12:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5e4acbd_diagnostics_wins_fda_clearance_for_new_molecular_/</loc>
		<lastmod>2018-07-04T15:12:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/20484genomic_health_begins_validation_study_ofcancer_/</loc>
		<lastmod>2018-07-04T15:12:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-eli-lilly-terminate-clinical-trials-of-alzheimers-disease-treatment-lanabecestat-120618-6202048/</loc>
		<lastmod>2018-07-04T15:12:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bridgebio-pharma-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion-120618-6202125/</loc>
		<lastmod>2018-07-04T15:12:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/advaxis-doses-first-patient-with-adxs-neo-cancer-immunotherapy-120618-6202865/</loc>
		<lastmod>2018-07-04T15:12:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b94a5elekta_wins_chinese_approval_for_linear_accelerator_d/</loc>
		<lastmod>2018-07-04T15:12:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d4a1dor_biopharma_raises_228_million_in_equity_fina/</loc>
		<lastmod>2018-07-04T15:12:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/374b1watson_and_warner_chilcott_sign_settlement_and_licensing_agree/</loc>
		<lastmod>2018-07-04T15:12:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/764bachina_pharma_wins_approval_for_tiopronin_entericcoated_cap/</loc>
		<lastmod>2018-07-04T15:12:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f44a5sutro_biopharma_names_ne/</loc>
		<lastmod>2018-07-04T15:12:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/de4b3cyberonics_names_new_vice_president_o/</loc>
		<lastmod>2018-07-04T15:12:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/514b1atrium_medical_establishes_new_specialty_healthcare_div/</loc>
		<lastmod>2018-07-04T15:12:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/064a8pharmasset_and_roche_win_fda_approval_for_phase_iib_hepatitis_/</loc>
		<lastmod>2018-07-04T15:12:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a549falexions_soliris_wins_orphan_drug_designation_in_/</loc>
		<lastmod>2018-07-04T15:12:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f2495inset_technologies_raises_25_million_in_equity_fina/</loc>
		<lastmod>2018-07-04T15:12:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6b489neogenix_oncology_acquires_patent_portfolio_fro/</loc>
		<lastmod>2018-07-04T15:12:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomimetic_completes_enrollment_in_augment_bone_graft_study_130109/</loc>
		<lastmod>2018-07-04T15:12:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioseek_and_ucb_expand_research_collaboration_130109/</loc>
		<lastmod>2018-07-04T15:12:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chiome_bioscience_and_chugai_pharmaceutical_sign_research_agreement_130109/</loc>
		<lastmod>2018-07-04T15:12:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/circassia_completes_recruitment_for_phase_ii_allergic_rhinitis_trial_130109/</loc>
		<lastmod>2018-07-04T15:12:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/escalon_completes_acquisition_of_hematology_business_from_biocode_hycel_130109/</loc>
		<lastmod>2018-07-04T15:12:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/galapagos_delivers_osteoarthritis_drug_in_alliance_with_gsk_130109/</loc>
		<lastmod>2018-07-04T15:12:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_completes_tender_offer_for_shares_of_genelabs_technologies_130109/</loc>
		<lastmod>2018-07-04T15:12:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/imquest_life_sciences_files_ind_application_for_hiv_drug_130109/</loc>
		<lastmod>2018-07-04T15:12:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/intellect_licenses_certain_alzheimers_patents_to_global_pharma_company_130109/</loc>
		<lastmod>2018-07-04T15:12:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/intradigm_secures_214_million_in_series_b_financing_130109/</loc>
		<lastmod>2018-07-04T15:12:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nomir_medical_wins_second_fda_approval_for_noveon_system_130109/</loc>
		<lastmod>2018-07-04T15:12:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/osteotech_initiates_study_of_duratech_bioregeneration_matrix_130109/</loc>
		<lastmod>2018-07-04T15:12:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/peplin_reports_positive_results_from_phase_iib_actinic_keratosis_trial_130109/</loc>
		<lastmod>2018-07-04T15:12:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pyng_medical_acquires_rights_to_emergency_surgical_airway_trainer_130109/</loc>
		<lastmod>2018-07-04T15:12:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/88498cara_therapeutics_initiates_phase_ii_postoperative_pain_/</loc>
		<lastmod>2018-07-04T15:12:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/15486champions_biotechnology_and_concordia_sign_royalty_agre/</loc>
		<lastmod>2018-07-04T15:12:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b34bfurigen_raises_257000_in_fina/</loc>
		<lastmod>2018-07-04T15:12:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a14aasri_signs_licensing_and_research_agreement_with_auricx_pharmaceut/</loc>
		<lastmod>2018-07-04T15:12:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0c4a7copernicus_therapeutics_and_university_of_kentucky_form_collabor/</loc>
		<lastmod>2018-07-04T15:12:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/47487asthmatx_files_pma_application_for_alair_bronchial_thermoplasty_s/</loc>
		<lastmod>2018-07-04T15:12:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/02490forma_therapeutics_signs_licensing_and_option_agreement_with_nov/</loc>
		<lastmod>2018-07-04T15:12:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/284b3sohm_signs_manufacturing_agreement_for_generic_pharmaceutical_pro/</loc>
		<lastmod>2018-07-04T15:12:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9649dsolace_pharmaceuticals_initiates_phase_iia_postherpetic_neuralgia_/</loc>
		<lastmod>2018-07-04T15:12:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a548brubicon_genomics_signs_licensing_agreement_with_a/</loc>
		<lastmod>2018-07-04T15:12:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e448dboehringer_ingelheim_names_new_evp_of_sales_and_mark/</loc>
		<lastmod>2018-07-04T15:12:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/124a6stem_cell_therapeutics_names_ne/</loc>
		<lastmod>2018-07-04T15:12:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bd4bcexact_sciences_rejects_acquisition_proposal_from_seq/</loc>
		<lastmod>2018-07-04T15:12:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3748dfacet_biotech_names_new_svp_of_commercial_and_corporate_develo/</loc>
		<lastmod>2018-07-04T15:12:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/06499singulex_secures_19_million_in_fina/</loc>
		<lastmod>2018-07-04T15:12:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genzyme_reports_preliminary_2008_results_090113/</loc>
		<lastmod>2018-07-04T15:12:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3a482imris_makes_senior_management_ch/</loc>
		<lastmod>2018-07-04T15:12:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e34b6prourocare_medical_prices_public_offer_/</loc>
		<lastmod>2018-07-04T15:12:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/264bdazur_pharma_licenses_cns_drugs_fro/</loc>
		<lastmod>2018-07-04T15:12:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qiagen_ledconsortium_launches_project_to_improve_invitro_diagnostics_090112/</loc>
		<lastmod>2018-07-04T15:12:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-to-buy-license-of-translates-mrna-technology-in-805m-deal-120618-6201715/</loc>
		<lastmod>2018-07-04T15:12:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-gets-ec-nod-for-tagrisso-as-first-line-treatment-for-egfr-mutated-nsclc-110618-6200327/</loc>
		<lastmod>2018-07-04T15:12:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-cellenkos-ind-to-begin-clinical-trial-of-ck0801-for-bone-marrow-failure-syndromes-110618-6200421/</loc>
		<lastmod>2018-07-04T15:12:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celerus_diagnostics_appoints_new_cfo_090112/</loc>
		<lastmod>2018-07-04T15:12:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6b484acclarent_raises_26_million_in_financ/</loc>
		<lastmod>2018-07-04T15:12:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0d4a2medasorb_makes_senior_management_changes_names_new_interi/</loc>
		<lastmod>2018-07-04T15:12:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/114a9xdx_and_bristolmyers_sign_collaboration_agre/</loc>
		<lastmod>2018-07-04T15:12:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a44b9ev3_names_new_senior_vice_president_an/</loc>
		<lastmod>2018-07-04T15:12:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alnylams-lumasiran-yields-positive-results-in-phase-12-hyperoxaluria-study-110618-6200184/</loc>
		<lastmod>2018-07-04T15:12:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-abbvie-and-roches-venclexta-rituximab-combo-for-cll-and-sll-110618-6200033/</loc>
		<lastmod>2018-07-04T15:12:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oncologie-commences-operations-in-boston-and-shanghai-080618-6198730/</loc>
		<lastmod>2018-07-04T15:12:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b44a1catalyst_reaches_enrollment_target_in_phase_ii_cocaine_addiction_/</loc>
		<lastmod>2018-07-04T15:12:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4148etheratechnologiess_chief_medical_officer_l/</loc>
		<lastmod>2018-07-04T15:12:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_provides_fullyear_earnings_guidance_for_2009_090112/</loc>
		<lastmod>2018-07-04T15:12:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mhra-chm-adopt-positive-opinion-on-approval-of-alliances-diclectin-080618-6198400/</loc>
		<lastmod>2018-07-04T15:12:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f9486alkermes_announces_initiation_of_phase_i_schizophrenia_/</loc>
		<lastmod>2018-07-04T15:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e54abtopigen_names_ne/</loc>
		<lastmod>2018-07-04T15:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentechs-rituxan-gets-fda-approval-for-treatment-of-pemphigus-vulgaris-070618-6198325/</loc>
		<lastmod>2018-07-04T15:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/axovant-oxford-biomedica-sign-8425m-deal-for-investigational-gene-therapy-of-parkinsons-disease-060618-6195289/</loc>
		<lastmod>2018-07-04T15:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4d4bbgsk_and_xenoport_resubmit_new_drug_application_for_so/</loc>
		<lastmod>2018-07-04T15:13:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac4b9anesiva_wins_fda_approval_to_expand_pain_drug_indic/</loc>
		<lastmod>2018-07-04T15:13:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/45488array_biopharma_initiates_dosing_in_phase_i_cancer_/</loc>
		<lastmod>2018-07-04T15:13:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c487immunogen_names_new_senior_vice_president_an/</loc>
		<lastmod>2018-07-04T15:13:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2f4bdesbatech_initiates_phase_iiia_osteoarthritis_/</loc>
		<lastmod>2018-07-04T15:13:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sirnaomics-secures-25m-to-expand-clinical-programs-of-anti-fibrosis-and-anti-cancer-rnai-therapeutics-070618-6196860/</loc>
		<lastmod>2018-07-04T15:13:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbvies-upadacitinib-succeeds-in-phase-3-trial-in-rheumatoid-arthritis-070618-6196722/</loc>
		<lastmod>2018-07-04T15:13:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-announces-600m-biotech-investment-through-venture-capital-arm-070618-6196580/</loc>
		<lastmod>2018-07-04T15:13:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/be494scn_signs_distribution_agreement_with_medica_clinical/</loc>
		<lastmod>2018-07-04T15:13:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/af4b6sirius_signs_collaboration_agreement_with_uk_critical_care_genomics_/</loc>
		<lastmod>2018-07-04T15:13:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/894bfintegra_lifesciences_acquires_omnitract_sur/</loc>
		<lastmod>2018-07-04T15:13:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4f483welichem_biotech_names_ne/</loc>
		<lastmod>2018-07-04T15:13:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c3485victory_pharma_launches_new_dosage_strengths_of_naprelan_prescription_pro/</loc>
		<lastmod>2018-07-04T15:13:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nimbus-therapeutics-secures-65m-to-accelerate-pipeline-progress-and-expand-discovery-effort-060618-6195117/</loc>
		<lastmod>2018-07-04T15:13:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hookipa-licenses-out-immunization-technologies-to-gilead-in-400m-deal-060618-6194978/</loc>
		<lastmod>2018-07-04T15:13:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-hemlibra-gets-fda-priority-review-for-haemophilia-a-without-inhibitors-060618-6194717/</loc>
		<lastmod>2018-07-04T15:13:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac492bionanomatrix_names_new_vice_president_of_engine/</loc>
		<lastmod>2018-07-04T15:13:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1d49dnovabay_wins_us_patent_for_new_antimicrobial_comp/</loc>
		<lastmod>2018-07-04T15:13:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mindray_reports_preliminary_2008_results_090112/</loc>
		<lastmod>2018-07-04T15:13:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c7485sinclair_pharma_signs_distribution_agreement_with_graceway_for_dermatitis/</loc>
		<lastmod>2018-07-04T15:13:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/34485ovations_seizure_drug_wins_positive_recommendation_from_fda_/</loc>
		<lastmod>2018-07-04T15:13:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-biocon-secure-fda-nod-for-first-biosimilar-to-cancer-drug-neulasta-050618-6193255/</loc>
		<lastmod>2018-07-04T15:13:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/enyo-pharma-secures-40m-funding-to-advance-development-of-hbv-and-nash-treatment-050618-6193272/</loc>
		<lastmod>2018-07-04T15:13:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/virpax-licenses-lipocures-liposome-drug-delivery-technology-050618-6193098/</loc>
		<lastmod>2018-07-04T15:13:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-lynparzaabiraterone-combo-benefits-prostate-cancer-patients-050618-6192941/</loc>
		<lastmod>2018-07-04T15:13:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-perjeta-approved-in-europe-for-her2-positive-early-breast-cancer-040618-6175558/</loc>
		<lastmod>2018-07-04T15:13:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-phase-iii-trial-shows-kisqali-combination-therapy-improves-pfs-in-hrher2-advanced-breast-cancer-040618-6175766/</loc>
		<lastmod>2018-07-04T15:13:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec485kolltan_secures_over_35_million_in_series_a_fina/</loc>
		<lastmod>2018-07-04T15:13:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/45496prism_to_obtain_10_million_milestone_payment_from_paul_capital_healt/</loc>
		<lastmod>2018-07-04T15:13:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1a4b2alcon_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:13:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/424b9oraldna_labs_to_provide_diagnostic_testing_services_for_midwest_d/</loc>
		<lastmod>2018-07-04T15:13:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly-and-incyte-bag-fda-approval-for-lower-dose-arthritis-drug-olumiant-040618-6175446/</loc>
		<lastmod>2018-07-04T15:13:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mercks-keytruda-shows-improved-orr-in-phase-2-renal-cell-carcinoma-study-040618-6175888/</loc>
		<lastmod>2018-07-04T15:13:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/syndax-nektar-therapeutics-announce-immuno-oncology-clinical-trial-collaboration-010618-6174081/</loc>
		<lastmod>2018-07-04T15:13:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synosia_raises_chf32_million_in_series_b_financing_090109/</loc>
		<lastmod>2018-07-04T15:13:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synta_and_roche_form_research_alliance_090109/</loc>
		<lastmod>2018-07-04T15:13:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vital_therapies_initiates_enrollment_in_phase_ii_study_of_liver_support_system_090109/</loc>
		<lastmod>2018-07-04T15:13:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/advaxis_wins_fda_approval_for_phase_ii_cin_trial_090109/</loc>
		<lastmod>2018-07-04T15:13:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amira_completes_toxicity_studies_for_allergic_inflammation_drug_090109/</loc>
		<lastmod>2018-07-04T15:13:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cancer-research-uk-ecmc-launch-trial-to-test-new-treatment-combination-for-children-and-adults-with-leukaemia-010618-6174062/</loc>
		<lastmod>2018-07-04T15:13:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/madrigals-liver-drug-succeeds-in-phase-2-clinical-trial-010618-6173827/</loc>
		<lastmod>2018-07-04T15:13:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssen-begins-phase-1b2-clinical-trial-to-assess-multiple-myeloma-treatment-310518-6172008/</loc>
		<lastmod>2018-07-04T15:13:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/antares_wins_450000_milestone_payment_from_biosante_pharmaceuticals_090109/</loc>
		<lastmod>2018-07-04T15:13:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-respiratory-drug-fasenra-fails-in-second-phase-3-copd-trial-310518-6171774/</loc>
		<lastmod>2018-07-04T15:13:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/argentiss_sclerosis_drug_wins_eu_positive_opinion_090109/</loc>
		<lastmod>2018-07-04T15:13:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/basi_wins_new_european_patent_for_culex_in_vivo_sampling_system_090109/</loc>
		<lastmod>2018-07-04T15:13:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomarin_and_la_jolla_sign_commercialization_agreement_for_lupus_drug_090109/</loc>
		<lastmod>2018-07-04T15:13:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytochroma_initiates_phase_i_chronic_kidney_disease_study_090109/</loc>
		<lastmod>2018-07-04T15:13:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-pfizers-xeljanz-as-oral-treatment-for-ulcerative-colitis-310518-6171616/</loc>
		<lastmod>2018-07-04T15:13:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-loxo-oncologys-nda-and-grants-priority-review-for-cancer-drug-larotrectinib-300518-6170207/</loc>
		<lastmod>2018-07-04T15:13:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/44498concentric_medical_raises_15_million_in_fina/</loc>
		<lastmod>2018-07-04T15:13:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b949dbristolmyers_names_new_vice_pres/</loc>
		<lastmod>2018-07-04T15:13:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e74b9genta_wins_two_new_us_patents_for_gallium_products_fran/</loc>
		<lastmod>2018-07-04T15:13:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/85481osiris_wins_5_million_milestone_payment_from_nuv/</loc>
		<lastmod>2018-07-04T15:13:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0e4aeamicus_therapeutics_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:13:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec-authorizes-clovis-oncologys-rubraca-to-treat-women-with-recurrent-ovarian-cancer-300518-6170226/</loc>
		<lastmod>2018-07-04T15:13:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ipsen-to-partner-with-md-anderson-to-develop-oncology-drug-300518-6170044/</loc>
		<lastmod>2018-07-04T15:13:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-tecentriq-chemo-combo-succeeds-in-phase-3-lung-cancer-trial-30-0518-6169900/</loc>
		<lastmod>2018-07-04T15:13:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b44abcentene_files_lawsuit_against_ameri/</loc>
		<lastmod>2018-07-04T15:13:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/32493palomar_and_qmed_terminate_distribution_agre/</loc>
		<lastmod>2018-07-04T15:13:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/olix-secures-cta-in-uk-to-start-phase-i-study-with-olx10010-290518-6168712/</loc>
		<lastmod>2018-07-04T15:13:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ab-science-plans-to-resubmit-marketing-application-for-als-treatment-masitinib-290518-6168530/</loc>
		<lastmod>2018-07-04T15:13:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/centogene-aldeyra-therapeutics-to-advance-novel-therapeutics-for-patients-with-sjgren-larsson-syndrome-290518-6168556/</loc>
		<lastmod>2018-07-04T15:13:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/83484scynexis_reports_positive_topline_results_from_phase_ib_hepatitis_/</loc>
		<lastmod>2018-07-04T15:13:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac481cvbt_opens_two_additional_sites_for_enrollment_of_phase_ii_heart_/</loc>
		<lastmod>2018-07-04T15:13:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f4495icon_completes_acquisition_of_remaining_stake_in_beacon_biosc/</loc>
		<lastmod>2018-07-04T15:13:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immupharmas-further-phase-iii-lupuzor-trial-analysis-shows-positive-results-in-europe-cohort-6168539/</loc>
		<lastmod>2018-07-04T15:13:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/midatech-begins-clinical-trial-of-mtx110-in-childhood-brain-cancer-280518-6166921/</loc>
		<lastmod>2018-07-04T15:13:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssen-to-stop-clinical-studies-of-cancer-treatment-daratumumab-280518-6166960/</loc>
		<lastmod>2018-07-04T15:13:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8449ejuvaris_reports_positive_results_from_phase_i_flu_vaccine_/</loc>
		<lastmod>2018-07-04T15:13:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7b499imany_licenses_contract_management_suite_to_sanofiav/</loc>
		<lastmod>2018-07-04T15:13:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1548fcovidien_wins_fda_clearance_for_sils_port_multiple_instrument_access/</loc>
		<lastmod>2018-07-04T15:13:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/254bbagendia_names_ne/</loc>
		<lastmod>2018-07-04T15:13:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a049fimpax_confirms_patent_challenge_of_muscle_spasm/</loc>
		<lastmod>2018-07-04T15:13:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/beactica-signs-three-year-extension-deal-with-sanofi-280518-6167035/</loc>
		<lastmod>2018-07-04T15:13:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-imfinzi-improves-overall-survival-of-certain-nsclc-patients-280518-6166695/</loc>
		<lastmod>2018-07-04T15:13:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sandoz-gets-ec-nod-for-zessly-to-treat-gastroenterological-rheumatological-and-dermatological-diseases-250418-6165488/</loc>
		<lastmod>2018-07-04T15:13:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c24aeangion_signs_licensing_option_with_memorial_sloan_kettering_cancer_c/</loc>
		<lastmod>2018-07-04T15:13:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/08488altus_completes_phase_i_study_of_recombinant_human_growth_ho/</loc>
		<lastmod>2018-07-04T15:13:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4e4a8acelrx_names_new_vice_president_of_clinical_develo/</loc>
		<lastmod>2018-07-04T15:13:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9e4a2optimedica_names_new_vice_president_o/</loc>
		<lastmod>2018-07-04T15:13:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/124adgenomic_health_names_ne/</loc>
		<lastmod>2018-07-04T15:13:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/malvern-panalytical-launches-zetasizer-pro-and-zetasizer-ultra-systems-250518-6165109/</loc>
		<lastmod>2018-07-04T15:13:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomarins-palynziq-injection-gets-fda-nod-for-treatment-of-phenylketonuria-250518-6165062/</loc>
		<lastmod>2018-07-04T15:13:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-refuses-to-approve-cosmos-nda-for-methylene-blue-mmx-240518-6163524/</loc>
		<lastmod>2018-07-04T15:13:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emergent_biosolutions_reports_preliminary_2008_results_090109/</loc>
		<lastmod>2018-07-04T15:13:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/depomeds_licensing_agreement_with_solvay_wins_hsr_clearance_080109/</loc>
		<lastmod>2018-07-04T15:13:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/endo_pharmaceuticals_to_acquire_indevus_pharmaceuticals_for_370_million_080109/</loc>
		<lastmod>2018-07-04T15:13:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eu_to_review_arks_maa_for_brain_cancer_drug_080109/</loc>
		<lastmod>2018-07-04T15:13:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/epigen-biosciences-to-license-lpa1-receptor-small-molecule-program-to-novo-nordisk-240518-6163542/</loc>
		<lastmod>2018-07-04T15:13:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/exonhit_extends_drug_discovery_collaboration_with_allergan_080109/</loc>
		<lastmod>2018-07-04T15:13:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cara-licenses-korsuva-injection-ex-us-rights-to-vfmcrp-in-520m-deal-240518-6163384/</loc>
		<lastmod>2018-07-04T15:13:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-to-quit-techpool-jv-in-china-in-280m-deal-230518-6161824/</loc>
		<lastmod>2018-07-04T15:13:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genmab_reports_interim_results_from_phase_iii_head_and_neck_cancer_study_080109/</loc>
		<lastmod>2018-07-04T15:13:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kythera_reports_positive_results_from_two_phase_ii_submental_fat_studies_080109/</loc>
		<lastmod>2018-07-04T15:13:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medimmune_files_maa_for_intranasal_influenza_vaccine_in_eu_080109/</loc>
		<lastmod>2018-07-04T15:13:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medtronic_initiates_enrollment_in_peripheral_arterial_disease_trial_080109/</loc>
		<lastmod>2018-07-04T15:13:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medtronic_launches_new_surgical_power_console_080109/</loc>
		<lastmod>2018-07-04T15:13:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/microdose_technologies_and_nexus6_form_rd_collaboration_080109/</loc>
		<lastmod>2018-07-04T15:14:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sbio_signs_collaboration_and_licensing_agreement_with_onyx_080109/</loc>
		<lastmod>2018-07-04T15:14:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sigma_aldrich_acquires_seppro_depletion_technology_from_genway_biotech_080109/</loc>
		<lastmod>2018-07-04T15:14:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sirona_launches_new_digital_impression_unit_080109/</loc>
		<lastmod>2018-07-04T15:14:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ucb_obtains_fda_complete_response_letter_for_arthritis_drug_080109/</loc>
		<lastmod>2018-07-04T15:14:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-to-review-zynquista-as-potential-treatment-for-type-1-diabetes-230518-6162003/</loc>
		<lastmod>2018-07-04T15:14:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wuxi-biologics-to-develop-biologics-manufacturing-facility-in-singapore-230518-6161987/</loc>
		<lastmod>2018-07-04T15:14:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celgene-forms-oncology-partnership-with-germany-based-evotec-230518-6161570/</loc>
		<lastmod>2018-07-04T15:14:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genomic_announces_executive_appointments_090108/</loc>
		<lastmod>2018-07-04T15:14:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vicor_wins_fda_clearance_to_market_its_pd2i_analyzer_080109/</loc>
		<lastmod>2018-07-04T15:14:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alivio-therapeutics-secures-two-us-patents-for-inflammation-targeting-technology-platform-220518-6160289/</loc>
		<lastmod>2018-07-04T15:14:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mds_reports_q4_fiscal_2008_results_090108/</loc>
		<lastmod>2018-07-04T15:14:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ym_biosciencess_drug_selected_for_phase_iii_head_and_neck_cancer_study_080109/</loc>
		<lastmod>2018-07-04T15:14:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ym_wins_canadian_approval_to_initiate_two_phase_ii_cancer_studies_080109/</loc>
		<lastmod>2018-07-04T15:14:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viiv-healthcare-gets-ec-nod-for-juluca-to-treat-hiv-1-infection-220518-6160137/</loc>
		<lastmod>2018-07-04T15:14:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/midatech-begins-dosing-in-first-human-trial-of-cancer-drug-q-octreotide-220518-6160007/</loc>
		<lastmod>2018-07-04T15:14:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dovas-doptelet-gets-fda-nod-for-thrombocytopenia-in-liver-disease-patients-210518-6159851/</loc>
		<lastmod>2018-07-04T15:14:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-two-phase-3-studies-show-hemlibra-reduces-bleeding-in-hemophilia-patients-210518-6158585/</loc>
		<lastmod>2018-07-04T15:14:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-astrazenecas-lokelma-to-treat-hyperkalemia-in-adults-210518-6158658/</loc>
		<lastmod>2018-07-04T15:14:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/millipore_appoints_new_bioscience_division_president_090108/</loc>
		<lastmod>2018-07-04T15:14:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/curevac_wins_approval_to_initiate_phase_iiia_prostate_cancer_vaccine_study_080109/</loc>
		<lastmod>2018-07-04T15:14:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/agendia_appoints_new_cfo_090108/</loc>
		<lastmod>2018-07-04T15:14:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cylene_initiates_phase_i_cancer_trial_080109/</loc>
		<lastmod>2018-07-04T15:14:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/response_genetics_plans_to_expands_sales_force_090108/</loc>
		<lastmod>2018-07-04T15:14:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/south-koreas-gc-pharma-establishes-vaccine-development-firm-curevo-210518-6158506/</loc>
		<lastmod>2018-07-04T15:14:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssens-erleada-shown-to-reduce-psa-progression-by-94-in-nmcrpc-patients-210518-6158220/</loc>
		<lastmod>2018-07-04T15:14:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1f4a5adhezion_wins_fda_clearance_for_surgiseal_topical_skin_adh/</loc>
		<lastmod>2018-07-04T15:14:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1a4b8velcura_therapeutics_to_initiate_rheumatoid_arthritis_t/</loc>
		<lastmod>2018-07-04T15:14:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c948bdaiichi_sankyo_sets_up_new_subsidiary_in_puerto/</loc>
		<lastmod>2018-07-04T15:14:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d44bfbiocontrol_medical_wins_ce_mark_for_cardiofit_sys/</loc>
		<lastmod>2018-07-04T15:14:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a4490gene_security_network_raises_6_million_in_series_b_fina/</loc>
		<lastmod>2018-07-04T15:14:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec-approves-ipsens-cabometyx-as-first-line-treatment-for-adults-with-intermediate-or-poor-risk-advanced-arcc-6156938/</loc>
		<lastmod>2018-07-04T15:14:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizers-lyrica-meets-primary-endpoint-in-phase-3-trial-of-pediatric-epilepsy-180518-6156922/</loc>
		<lastmod>2018-07-04T15:14:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-and-amgen-secure-fda-approval-for-migraine-drug-180518-6156668/</loc>
		<lastmod>2018-07-04T15:14:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristolmyers_appoints_vice_president_and_therapeutic_area_head_global_clinical_research_neuroscience_090108/</loc>
		<lastmod>2018-07-04T15:14:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8748bmarshall_edwards_wins_ind_approval_for_cancer/</loc>
		<lastmod>2018-07-04T15:14:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a7499auspex_pharmaceuticals_names_new_ceo_an/</loc>
		<lastmod>2018-07-04T15:14:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/314a3gi_dynamics_wins_ce_mark_for_endobarrier_gastrointestinal_liner_s/</loc>
		<lastmod>2018-07-04T15:14:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/164a2qmed_wins_chinese_approval_for_wrinkle/</loc>
		<lastmod>2018-07-04T15:14:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/optibiotix-health-akums-sign-exclusive-manufacturing-and-supply-agreement-for-india-170518-6155062/</loc>
		<lastmod>2018-07-04T15:14:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/idmc-recommends-to-expand-tizianas-milciclib-liver-cancer-trial-170518-6155057/</loc>
		<lastmod>2018-07-04T15:14:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a0489achillion_names_new_head_of_business_develo/</loc>
		<lastmod>2018-07-04T15:14:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/684b2liquidia_signs_collaboration_and_licensing_agreement_with_a/</loc>
		<lastmod>2018-07-04T15:14:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0049bmiddlebrook_pharmaceuticals_to_introduce_moxatag_ta/</loc>
		<lastmod>2018-07-04T15:14:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a04b5skyepharmas_partner_nitec_wins_european_approval_for_arthritis_d/</loc>
		<lastmod>2018-07-04T15:14:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hifibio-therapeutics-secures-375m-funding-for-novel-cancer-and-autoimmune-drugs-170518-6155384/</loc>
		<lastmod>2018-07-04T15:14:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/surface-pharmaceuticals-secures-20m-funding-from-flying-l-partners-160518-6153210/</loc>
		<lastmod>2018-07-04T15:14:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/314b9biomedical_enterprises_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:14:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-completes-87bn-acquisition-of-avexis-160518-6153174/</loc>
		<lastmod>2018-07-04T15:14:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-pfizers-epoetin-alfa-biosimilar-retacrit-to-treat-anemia-160518-6153029/</loc>
		<lastmod>2018-07-04T15:14:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zymeworks-daiichi-sankyo-expand-immuno-oncology-collaboration-150518-6151612/</loc>
		<lastmod>2018-07-04T15:14:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aquestive-settles-patent-infringement-case-with-par-pharmaceuticals-150518-6151539/</loc>
		<lastmod>2018-07-04T15:14:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/93482sun_pharma_wins_fda_approval_for_four_generic_/</loc>
		<lastmod>2018-07-04T15:14:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b495volcano_closes_acquisition_of_axsun_technol/</loc>
		<lastmod>2018-07-04T15:14:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/88490pmi_names_new_senior_vice_president_of_global_sales__mark/</loc>
		<lastmod>2018-07-04T15:14:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d44a9facet_biotech_to_axe_80/</loc>
		<lastmod>2018-07-04T15:14:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f6481meridian_wins_fda_approval_for_lapex_bcs_laser_d/</loc>
		<lastmod>2018-07-04T15:14:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly-to-acquire-aurka-pharma-from-tvm-capital-in-575m-worth-deal-150518-6151284/</loc>
		<lastmod>2018-07-04T15:14:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-copd-drug-fasenra-fails-to-meet-primary-endpoint-in-galathea-phase-iii-trial-140518-6150207/</loc>
		<lastmod>2018-07-04T15:14:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hemogenyx-collaborates-with-undisclosed-global-pharmaceutical-firm-on-cdx-antibodies-development-140518-6150011/</loc>
		<lastmod>2018-07-04T15:14:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f9490lilly_obtains_fda_complete_response_letter_for_schizophrenia/</loc>
		<lastmod>2018-07-04T15:14:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/89495anaphore_raises_25_million_in_series_a_fina/</loc>
		<lastmod>2018-07-04T15:14:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f04bdacuspheres_senior_vice_president_of_clinical_research_re/</loc>
		<lastmod>2018-07-04T15:14:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b49acolumbia_laboratories_raises_750000_in_equity_fina/</loc>
		<lastmod>2018-07-04T15:14:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d5493daiichi_sankyo_files_application_for_dysuria/</loc>
		<lastmod>2018-07-04T15:14:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rxi-iovance-partner-on-rnai-and-cell-therapy-based-cancer-treatments-140518-6149883/</loc>
		<lastmod>2018-07-04T15:14:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-expands-approval-of-novartis-ms-drug-gilenya-in-pediatric-patients-140518-6149737/</loc>
		<lastmod>2018-07-04T15:14:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amryt-aegerion-sign-expanded-deal-for-lojuxta-capsules-110518-6148769/</loc>
		<lastmod>2018-07-04T15:14:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b1487mds_pharma_services_names_ne/</loc>
		<lastmod>2018-07-04T15:14:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c04afcodexis_signs_licensing_agreement_with/</loc>
		<lastmod>2018-07-04T15:14:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rosetta_genomics_signs_distribution_agreement_with_teva_090108/</loc>
		<lastmod>2018-07-04T15:14:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/594b3horizon_therapeutics_makes_management_ch/</loc>
		<lastmod>2018-07-04T15:14:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d4afclx_medical_names_new_board_chair/</loc>
		<lastmod>2018-07-04T15:14:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-committee-recommends-approval-of-akceas-familial-chylomicronemia-syndrome-therapy-110518-6148223/</loc>
		<lastmod>2018-07-04T15:14:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly-to-acquire-immuno-oncology-company-armo-for-16bn-110518-6147983/</loc>
		<lastmod>2018-07-04T15:14:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech-lodo-therapeutics-sign-969m-drug-discovery-deal-100518-6146656/</loc>
		<lastmod>2018-07-04T15:14:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/13480warner_chilcott_signs_us_licensing_agreement_with_donga_phar/</loc>
		<lastmod>2018-07-04T15:14:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perkinelmer_and_idbs_announce_software_collaboration_080109/</loc>
		<lastmod>2018-07-04T15:14:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/valeant_completes_acquisition_of_dow_pharmaceutical_sciences_070109/</loc>
		<lastmod>2018-07-04T15:14:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches_subsidiary_purchases_shares_in_tender_offer_for_memory_pharmaceuticals_070109/</loc>
		<lastmod>2018-07-04T15:14:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/galapagos_to_advance_cachexia_drug_into_preclinical_development_070109/</loc>
		<lastmod>2018-07-04T15:14:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ee4bddaiichi_sankyo_to_acquire_controlling_interest_in_ra/</loc>
		<lastmod>2018-07-04T15:14:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/new-firm-escient-launches-to-develop-gpcr-targeted-drugs-100518-6146374/</loc>
		<lastmod>2018-07-04T15:14:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/forma-therapeutics-university-of-oxford-to-advance-development-of-dub-inhibitors-to-treat-neurodegenerative-diseases-100518-6146380/</loc>
		<lastmod>2018-07-04T15:14:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-turns-down-lipocines-application-for-oral-testosterone-product-tlando-100518-6146082/</loc>
		<lastmod>2018-07-04T15:14:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bdsi_extends_medas_rights_to_pain_drug_070109/</loc>
		<lastmod>2018-07-04T15:14:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acura_and_king_pharmaceuticals_file_nda_for_pain_drug_070109/</loc>
		<lastmod>2018-07-04T15:14:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dor_wins_fda_clearance_to_initiate_phase_iii_graft_versus_host_disease_study_070109/</loc>
		<lastmod>2018-07-04T15:14:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7f4a7uspto_accepts_pfizers_reissue_application_on_lipitor_enantiomer_p/</loc>
		<lastmod>2018-07-04T15:14:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3c4a3cytrx_names_ne/</loc>
		<lastmod>2018-07-04T15:14:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eb489pacira_completes_enrollment_in_two_phase_iii_pain_st/</loc>
		<lastmod>2018-07-04T15:14:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b0489dor_biopharma_wins_fda_fast_track_status_for_enteritis/</loc>
		<lastmod>2018-07-04T15:14:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b84a4emergent_biosolutions_ends_bid_to_acquire_protein_scien/</loc>
		<lastmod>2018-07-04T15:14:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/374a8boston_scientific_acquires_la/</loc>
		<lastmod>2018-07-04T15:14:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4548fanacor_secures_50_million_in_equity_fina/</loc>
		<lastmod>2018-07-04T15:14:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-merck-get-eu-nod-for-ovarian-cancer-drug-lynparza-090518-6144656/</loc>
		<lastmod>2018-07-04T15:14:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medidata-releases-new-ai-based-clinical-trial-software-trial-assurance-090518-6144663/</loc>
		<lastmod>2018-07-04T15:14:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-relypsa-snda-to-use-veltassa-with-or-without-food-090518-6144672/</loc>
		<lastmod>2018-07-04T15:14:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c149binspires_phase_iii_cystic_fibrosis_trial_meets_end_/</loc>
		<lastmod>2018-07-04T15:14:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/214b7halozyme_obtains_55_million_payment_from_b/</loc>
		<lastmod>2018-07-04T15:14:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f749fpromedior_names_ne/</loc>
		<lastmod>2018-07-04T15:14:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a24a9valeant_names_new_coo_of_specialty_pharmaceut/</loc>
		<lastmod>2018-07-04T15:14:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2249bstockeryale_signs_supply_agreement_with_boston_scien/</loc>
		<lastmod>2018-07-04T15:14:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/japans-takeda-signs-deal-to-acquire-shire-for-453bn-090518-6144521/</loc>
		<lastmod>2018-07-04T15:14:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-luye-pharma-sign-deal-for-two-anti-psychotic-medicines-080518-6142900/</loc>
		<lastmod>2018-07-04T15:14:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lannett-acquires-generic-products-from-endo-080518-6142826/</loc>
		<lastmod>2018-07-04T15:14:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c54bfquantrx_wins_fda_clearance_for_rapidsense_methamphetamine/</loc>
		<lastmod>2018-07-04T15:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8a4bcchimerix_completes_phase_i_study_of_antiviral/</loc>
		<lastmod>2018-07-04T15:15:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c548bimpulse_monitoring_and_hma_sign_agre/</loc>
		<lastmod>2018-07-04T15:15:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aa4aeabbott_completes_acquisition_of_ibis_biosci/</loc>
		<lastmod>2018-07-04T15:15:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d748fomeros_wins_465000_grant_to_evaluate_new_parkinsons_disease_t/</loc>
		<lastmod>2018-07-04T15:15:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc4b1pharmeng_signs_new_supply_agreement_with_consumer_healthcare_co/</loc>
		<lastmod>2018-07-04T15:15:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amneal-impax-complete-business-combination-6142906/</loc>
		<lastmod>2018-07-04T15:15:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-tecentriq-gets-fda-priority-review-for-type-of-metastatic-lung-cancer-080518-6142648/</loc>
		<lastmod>2018-07-04T15:15:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/index-pharmaceuticals-develops-oral-formulation-of-cobitolimod-070518-6142102/</loc>
		<lastmod>2018-07-04T15:15:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/684afbioreliance_wins_supply_contract_from_barr_pharmaceut/</loc>
		<lastmod>2018-07-04T15:15:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/124b7cellectis_terminates_genoways_recombination_technology_li/</loc>
		<lastmod>2018-07-04T15:15:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-tafinlarmekinist-gets-fda-nod-for-anaplastic-thyroid-cancer-070518-6141122/</loc>
		<lastmod>2018-07-04T15:15:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e649egalderma_introduces_new_topical_acne/</loc>
		<lastmod>2018-07-04T15:15:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bf481quinnova_pharmaceuticals_introduces_neo/</loc>
		<lastmod>2018-07-04T15:15:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7e492depomed_makes_management_promo/</loc>
		<lastmod>2018-07-04T15:15:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uks-horizon-discovery-rejects-270m-takeover-proposal-from-abcam-040518-6139269/</loc>
		<lastmod>2018-07-04T15:15:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/55480cubist_files_two_inds_for_antibiotic/</loc>
		<lastmod>2018-07-04T15:15:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/monarc-bionetworks-announces-strategic-integration-with-roivant-drug-development-platform-040518-6139295/</loc>
		<lastmod>2018-07-04T15:15:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immucor_declare_q2_fiscal_2009_results_090107/</loc>
		<lastmod>2018-07-04T15:15:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b14bfups_selected_by_merck_to_manage_distribution_/</loc>
		<lastmod>2018-07-04T15:15:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b74a7impax_names_new_president_of_global_pharmaceuticals_div/</loc>
		<lastmod>2018-07-04T15:15:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0a483proteonomix_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:15:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/third-rock-launches-new-biotechnology-company-casma-therapeutics-040518-6139050/</loc>
		<lastmod>2018-07-04T15:15:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-partners-with-moderna-to-advance-mrna-kras-cancer-vaccine-040518-6138950/</loc>
		<lastmod>2018-07-04T15:15:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/054a0genego_renews_agreement_with_bayer_schering_p/</loc>
		<lastmod>2018-07-04T15:15:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/70498fasgen_signs_research_and_licensing_agreement_with_cen/</loc>
		<lastmod>2018-07-04T15:15:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e44aakiadis_pharma_names_new_chief_medical_of/</loc>
		<lastmod>2018-07-04T15:15:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1a4b5northstar_neuroscience_to_liquidate_its_a/</loc>
		<lastmod>2018-07-04T15:15:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-rejects-sandozs-bla-for-proposed-biosimilar-rituximab-030518-6137554/</loc>
		<lastmod>2018-07-04T15:15:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/onkure-secures-financing-to-support-development-of-epigenetics-drug-030518-6137567/</loc>
		<lastmod>2018-07-04T15:15:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-partners-with-sfj-to-develop-abituzumab-in-colorectal-cancer-030518-6137428/</loc>
		<lastmod>2018-07-04T15:15:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/254a2crucell_signs_licensing_agreement_with_cen/</loc>
		<lastmod>2018-07-04T15:15:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3a4a0perkinelmer_introduces_new_screening_s/</loc>
		<lastmod>2018-07-04T15:15:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/iris_international_board_member_richard_williams_to_retire_090107/</loc>
		<lastmod>2018-07-04T15:15:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nektar_closes_sale_of_pulmonary_delivery_assets_to_novartis_060109/</loc>
		<lastmod>2018-07-04T15:15:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_to_review_lilly_and_daiichis_anticlotting_drug_060109/</loc>
		<lastmod>2018-07-04T15:15:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssen-biotech-to-acquire-benevir-biopharm-in-104bn-deal-030518-6137210/</loc>
		<lastmod>2018-07-04T15:15:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vivus-to-acquire-pancreaze-for-135m-from-janssen-020518-6135690/</loc>
		<lastmod>2018-07-04T15:15:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c4xd-e-therapeutics-to-collaborate-on-treatment-of-parkinsons-disease-020518-6135672/</loc>
		<lastmod>2018-07-04T15:15:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/impax_sued_over_copy_of_infection_drug_doryx_060109/</loc>
		<lastmod>2018-07-04T15:15:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-kymriah-bags-fda-approval-for-treatment-of-large-b-cell-lymphoma-020518-6135514/</loc>
		<lastmod>2018-07-04T15:15:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mercks-keytruda-gets-fda-priority-review-for-first-line-nsclc-treatment-010518-6134203/</loc>
		<lastmod>2018-07-04T15:15:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nxdc-announces-acquisition-by-german-biotech-firm-010518-6134302/</loc>
		<lastmod>2018-07-04T15:15:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pdl_biopharma_and_alexion_settle_patent_dispute_060109/</loc>
		<lastmod>2018-07-04T15:15:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/87498power_medical_interventions_names_ne/</loc>
		<lastmod>2018-07-04T15:15:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9e4a7quidels_ceo_to_r/</loc>
		<lastmod>2018-07-04T15:15:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6848dxoma_names_ne/</loc>
		<lastmod>2018-07-04T15:15:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/344a1orexigen_granted_new_patent_for_obesity/</loc>
		<lastmod>2018-07-04T15:15:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/karyopharms-multiple-myeloma-drug-selinexor-succeeds-in-phase-2b-study-010518-6134023/</loc>
		<lastmod>2018-07-04T15:15:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ani-pharmaceuticals-to-buy-generic-products-from-amneal-and-impax-300418-6133013/</loc>
		<lastmod>2018-07-04T15:15:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/phoremost-neophore-get-grant-for-small-molecule-cancer-immunotherapy-300418-6132825/</loc>
		<lastmod>2018-07-04T15:15:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5a483emergent_initiates_us_phase_ii_typhoid_vaccine_/</loc>
		<lastmod>2018-07-04T15:15:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/384b9cigna_to_axe_1100/</loc>
		<lastmod>2018-07-04T15:15:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/474afppd_acquires_mercks_vaccine_testin/</loc>
		<lastmod>2018-07-04T15:15:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b4baensysce_biosciences_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:15:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e14a6dca_acquires_dialysis_center_in_mar/</loc>
		<lastmod>2018-07-04T15:15:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d490prism_pharmaceuticals_wins_fda_approval_for_cardiac_arrhythmia/</loc>
		<lastmod>2018-07-04T15:15:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-tagrisso-gets-positive-eu-chmp-opinion-for-first-line-treatment-of-egfr-mutated-nsclc-300418-6132899/</loc>
		<lastmod>2018-07-04T15:15:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allergans-ubrogepant-succeeds-in-second-phase-3-migraine-trial-300418-6132551/</loc>
		<lastmod>2018-07-04T15:15:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/omeros-oms721-gets-fda-breakthrough-therapy-designation-for-hsct-tma-270418-6130934/</loc>
		<lastmod>2018-07-04T15:15:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c748cteva_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:15:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2e4b0oni_biopharma_names_new_director_o/</loc>
		<lastmod>2018-07-04T15:15:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/prognostix_receives_055_million_grant_from_gcic_090106/</loc>
		<lastmod>2018-07-04T15:15:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vasogen_provides_corporate_update_090106/</loc>
		<lastmod>2018-07-04T15:15:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neogen_reports_q2_fiscal_2009_results_090106/</loc>
		<lastmod>2018-07-04T15:15:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca4abatrium_acquires_nutrihealth_supple/</loc>
		<lastmod>2018-07-04T15:15:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/misonix_signs_new_distribution_agreement_with_alliance_lithomobile_090105/</loc>
		<lastmod>2018-07-04T15:15:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/illumina_appoints_senior_vice_president_operations_090105/</loc>
		<lastmod>2018-07-04T15:15:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9748censign_acquires_southland_healthcare_c/</loc>
		<lastmod>2018-07-04T15:15:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/de4a3ra_group_holdings_completes_acquisition_of_national_renal_all/</loc>
		<lastmod>2018-07-04T15:15:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b48cresponse_genetics_amends_master_service_agreement_wit/</loc>
		<lastmod>2018-07-04T15:15:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/68497adaltis_names_new_vicepresident_of_fi/</loc>
		<lastmod>2018-07-04T15:15:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aa4b1illumina_names_new_senior_vice_president_of_opera/</loc>
		<lastmod>2018-07-04T15:15:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6749eimmunodiagnostic_systems_divests_hematology_unit_to_escalon_me/</loc>
		<lastmod>2018-07-04T15:15:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/41488asterand_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:15:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medmira_board_chairman_retires_090105/</loc>
		<lastmod>2018-07-04T15:15:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quidel_president_and_ceo_to_retire_090105/</loc>
		<lastmod>2018-07-04T15:15:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca_spends_13_million_on_lobbying_in_3q_2008_090105/</loc>
		<lastmod>2018-07-04T15:15:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xenoport_to_raise_40m_in_registered_direct_financing_020109/</loc>
		<lastmod>2018-07-04T15:15:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b48camerigroup_terminates_agreement_to_buy_certain_assets_of_university_health/</loc>
		<lastmod>2018-07-04T15:15:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/844abdr_reddys_names_ne/</loc>
		<lastmod>2018-07-04T15:15:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/74497fda_extends_review_of_king_pharmaceuticalss_embeda_extended_release_cap/</loc>
		<lastmod>2018-07-04T15:15:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/66487emea_validates_scheringploughs_corifollitropin/</loc>
		<lastmod>2018-07-04T15:15:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/104bawatson_wins_fda_approval_for_generic_nicorette_min/</loc>
		<lastmod>2018-07-04T15:15:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac4b4metiscan_completes_acquisition_of_two_diagnostic_imaging_facil/</loc>
		<lastmod>2018-07-04T15:15:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c64adinvacare_names_new_senior_vice_president_and_general_co/</loc>
		<lastmod>2018-07-04T15:15:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fa495pricara_recalls_50mcghr_duragesic_cii_pain_pa/</loc>
		<lastmod>2018-07-04T15:15:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gtx_files_new_drug_application_for_bone_fracture_therapy_020109/</loc>
		<lastmod>2018-07-04T15:15:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_accepts_savients_bla_for_gout_drug_020109/</loc>
		<lastmod>2018-07-04T15:15:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adaltis_appoints_new_vicepresident_finance_090102/</loc>
		<lastmod>2018-07-04T15:15:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actavis_acquires_pain_drug_from_king_pharmaceuticals_020109/</loc>
		<lastmod>2018-07-04T15:15:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biovail_recalls_certain_lots_of_ultram_er_100mg_tablets_020109/</loc>
		<lastmod>2018-07-04T15:15:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytori_announces_issuance_of_new_patent_to_university_of_california_020109/</loc>
		<lastmod>2018-07-04T15:15:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/king_pharmaceuticals_acquires_alpharma_020109/</loc>
		<lastmod>2018-07-04T15:15:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/974aalabopharm_wins_fda_approval_for_pain_dru/</loc>
		<lastmod>2018-07-04T15:15:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche_wins_fda_approval_for_blood_screening_test_020109/</loc>
		<lastmod>2018-07-04T15:15:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/264b8akornstrides_wins_fda_approval_for_two_generic_antibi/</loc>
		<lastmod>2018-07-04T15:15:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/health_robotics_licenses_robotics_services_to_devon_international_020109/</loc>
		<lastmod>2018-07-04T15:16:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/salix_receives_fda_complete_response_letter_for_ulcerative_colitis_drug_311208/</loc>
		<lastmod>2018-07-04T15:16:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8948achina_medical_technologies_divests_hifu_business_to_chengxuan_internat/</loc>
		<lastmod>2018-07-04T15:16:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4948bstryker_endoscopy_launches_wise_hdtv_embedded_with_amimons_techn/</loc>
		<lastmod>2018-07-04T15:16:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pacgen_terminates_letter_of_intent_with_medigen_311208/</loc>
		<lastmod>2018-07-04T15:16:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vertex-launches-phase-3-trials-of-vx-445tezacaftorivacaftor-combo-in-cystic-fibrosis-270418-6131145/</loc>
		<lastmod>2018-07-04T15:16:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/endo-to-acquire-somerset-therapeutics-and-wintac-for-190m-270418-6131126/</loc>
		<lastmod>2018-07-04T15:16:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/valirx-secures-eu-patent-grant-for-prostate-cancer-treatment-val201-260418-6129636/</loc>
		<lastmod>2018-07-04T15:16:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adc-therapeutics-terminates-adct-502-program-targeting-her2-expressing-solid-tumors-260418-6129649/</loc>
		<lastmod>2018-07-04T15:16:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/corvidia-therapeutics-raises-60m-funding-to-accelerate-clinical-work-260418-6129473/</loc>
		<lastmod>2018-07-04T15:16:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-expands-gsks-trelegy-ellipta-indication-in-copd-250418-6127893/</loc>
		<lastmod>2018-07-04T15:16:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-lung-cancer-combo-fails-in-phase-3-trial-250418-6127879/</loc>
		<lastmod>2018-07-04T15:16:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire-to-recommend-takedas-64bn-offer-to-shareholders-250418-6127675/</loc>
		<lastmod>2018-07-04T15:16:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/prothena-stops-development-of-al-amyloidosis-treatment-neod001-240418-6126344/</loc>
		<lastmod>2018-07-04T15:16:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celgene-expands-bispecific-antibody-collaboration-with-zymeworks-240418-6126232/</loc>
		<lastmod>2018-07-04T15:16:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/university-of-lincoln-scientists-develops-new-drug-design-technology-for-smarter-drugs-240418-6126379/</loc>
		<lastmod>2018-07-04T15:16:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizers-trastuzumab-biosimilar-fails-to-get-fda-approval-240418-6126090/</loc>
		<lastmod>2018-07-04T15:16:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogen-ionis-sign-1bn-deal-to-develop-novel-drug-candidates-for-neurological-diseases-230418-6124792/</loc>
		<lastmod>2018-07-04T15:16:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synpromics-to-partner-with-lonza-to-develop-inducible-promoter-platform-230418-6124769/</loc>
		<lastmod>2018-07-04T15:16:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fresenius-kabi-scraps-43bn-merger-with-us-generic-drugmaker-akorn-230418-6124570/</loc>
		<lastmod>2018-07-04T15:16:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/helperby-therapeutics-combination-antibiotic-therapy-is-effective-against-who-critical-priority-pathogen-in-phase-1-study-200418-6123400/</loc>
		<lastmod>2018-07-04T15:16:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tmunity-raises-35m-in-new-funding-to-advance-t-cell-therapies-200418-6123117/</loc>
		<lastmod>2018-07-04T15:16:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire-rejects-63bn-takeover-proposal-from-takeda-200418-6122956/</loc>
		<lastmod>2018-07-04T15:16:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/benevolentai-secures-115m-funding-to-advance-ai-enabled-drug-development-activities-190418-6121705/</loc>
		<lastmod>2018-07-04T15:16:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-tagrisso-as-first-line-treatment-for-egfr-mutated-non-small-cell-lung-cancer-190418-6121728/</loc>
		<lastmod>2018-07-04T15:16:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sandoz-pear-to-develop-digital-therapeutics-for-substance-use-disorder-190418-6121611/</loc>
		<lastmod>2018-07-04T15:16:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-to-sell-consumer-health-business-to-pg-for-42bn-190418-6121431/</loc>
		<lastmod>2018-07-04T15:16:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-hemlibra-gets-fda-breakthrough-therapy-status-to-treat-haemophilia-a-without-inhibitors-180418-6119933/</loc>
		<lastmod>2018-07-04T15:16:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/catabasis-to-restructure-business-to-focus-on-dmd-drug-180418-6119982/</loc>
		<lastmod>2018-07-04T15:16:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-announces-100m-to-advance-research-and-develop-next-generation-antimalarials-180418-6119956/</loc>
		<lastmod>2018-07-04T15:16:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/advent-international-in-talks-with-sanofi-to-buy-zentiva-for-19bn-180418-6119645/</loc>
		<lastmod>2018-07-04T15:16:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alliance-pharma-divests-60-stake-in-unigreg-170418-6118250/</loc>
		<lastmod>2018-07-04T15:16:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-lilly-university-of-oxford-to-study-empagliflozin-in-chronic-kidney-disease-170418-6118101/</loc>
		<lastmod>2018-07-04T15:16:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bms-opdivo-yervoy-regimen-gets-fda-approval-for-advanced-kidney-cancer-170418-6117969/</loc>
		<lastmod>2018-07-04T15:16:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/servier-to-buy-shires-oncology-business-for-24bn-160418-6116848/</loc>
		<lastmod>2018-07-04T15:16:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mercks-keytruda-significantly-decreases-risk-of-disease-recurrence-in-melanoma-study-160418-6116586/</loc>
		<lastmod>2018-07-04T15:16:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-tagrisso-shows-sustained-pfs-in-phase-3-lung-cancer-trial-160418-6116380/</loc>
		<lastmod>2018-07-04T15:16:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-to-invest-350m-for-new-vaccine-manufacturing-facility-in-toronto-130418-6114862/</loc>
		<lastmod>2018-07-04T15:16:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inovio-secures-56m-from-cepi-to-advance-dna-vaccines-against-lassa-fever-and-mers-130418-6114871/</loc>
		<lastmod>2018-07-04T15:16:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/orchard-therapeutics-to-acquire-gsks-rare-disease-gene-therapy-portfolio-130418-6114608/</loc>
		<lastmod>2018-07-04T15:16:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/personalized-tumor-vaccine-shows-significant-effect-in-pilot-trial-120418-6113367/</loc>
		<lastmod>2018-07-04T15:16:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/574a5eos_announces_development_update_for_melanoma_detection_d/</loc>
		<lastmod>2018-07-04T15:16:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/094b1health_robotics_licenses_robotics_solutions_to_devon_international_/</loc>
		<lastmod>2018-07-04T15:16:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/734b3scantek_medical_files_for_chapter_11_voluntary_bankr/</loc>
		<lastmod>2018-07-04T15:16:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ipsen_receives_fda_complete_response_letter_for_dysports_bla_311208/</loc>
		<lastmod>2018-07-04T15:16:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/624b7johnson__johnson_completes_acquisition_of_omrix_biopharmaceut/</loc>
		<lastmod>2018-07-04T15:16:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-fujifilm-kyowa-to-commercialize-humira-biosimilar-120418-6113171/</loc>
		<lastmod>2018-07-04T15:16:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alexion-to-acquire-swedish-biotech-firm-wilson-therapeutics-for-855m-120418-6112946/</loc>
		<lastmod>2018-07-04T15:16:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-to-buy-global-marketing-rights-of-mapis-glatiramer-acetate-product-110418-6111559/</loc>
		<lastmod>2018-07-04T15:16:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/394b8gsk_extends_tender_offer_to_acquire_genel/</loc>
		<lastmod>2018-07-04T15:16:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f84bbaurobindo_wins_fda_approval_for_stavudine_capsules_and_oral_sol/</loc>
		<lastmod>2018-07-04T15:16:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actavis_totowa_reaches_agreement_with_fda_on_consent_decree_311208/</loc>
		<lastmod>2018-07-04T15:16:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ed4bbmoog_acquires_aitecs_medical_for_e15_mi/</loc>
		<lastmod>2018-07-04T15:16:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/41496icad_launches_secondlook_digital_cad_technology_outside_/</loc>
		<lastmod>2018-07-04T15:16:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/promethera-biosciences-acquires-swiss-firm-baliopharm-110418-6111650/</loc>
		<lastmod>2018-07-04T15:16:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-likely-to-stop-phase-3-atlas-trial-of-kidney-cancer-drug-inlyta-6111366/</loc>
		<lastmod>2018-07-04T15:16:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uk-prime-minister-announces-75m-funding-to-support-prostate-cancer-studies-110418-6111959/</loc>
		<lastmod>2018-07-04T15:16:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/constellation-pharmaceuticals-raises-100m-financing-to-advance-multiple-clinical-trials-100418-6110261/</loc>
		<lastmod>2018-07-04T15:16:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/verastems-lymphoma-drug-duvelisib-gets-fda-priority-review-designation-100418-6109968/</loc>
		<lastmod>2018-07-04T15:16:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-licenses-nash-drug-from-ionis-in-300m-deal-100418-6109818/</loc>
		<lastmod>2018-07-04T15:16:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbvies-upadacitinib-meets-primary-and-secondary-endpoints-rheumatoid-arthritis-trial-100418-6110423/</loc>
		<lastmod>2018-07-04T15:17:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novo-nordisk-secures-exclusive-worldwide-licence-to-epidestinys-sickle-cell-disease-program-090318-6108788/</loc>
		<lastmod>2018-07-04T15:17:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clovis-rubraca-approved-as-maintenance-treatment-of-recurrent-ovarian-cancer-in-us-090418-6108737/</loc>
		<lastmod>2018-07-04T15:17:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-to-acquire-us-gene-therapy-company-avexis-for-87bn-090418-6108620/</loc>
		<lastmod>2018-07-04T15:17:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/epacadostat-keytruda-combination-therapy-fails-to-meet-primary-endpoint-in-cancer-drug-trial-090418-6108530/</loc>
		<lastmod>2018-07-04T15:17:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/indivior-lodges-complaints-asserting-new-suboxone-film-patent-against-anda-filers-060418-6106413/</loc>
		<lastmod>2018-07-04T15:17:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ferring-pharmaceuticals-to-buy-us-firm-rebiotix-06418-6106225/</loc>
		<lastmod>2018-07-04T15:17:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eidos-therapeutics-completes-64m-in-funding-led-by-ra-capital-management-060418-6106496/</loc>
		<lastmod>2018-07-04T15:17:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/proteostasis-triple-combination-program-secures-fda-fast-track-designation-for-cystic-fibrosis-050418-6105018/</loc>
		<lastmod>2018-07-04T15:17:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-acquires-inception-neuroscience-program-050418-6105058/</loc>
		<lastmod>2018-07-04T15:17:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3949axenoport_to_raise_40_million_in_registered_direct_fina/</loc>
		<lastmod>2018-07-04T15:17:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e64absalient_surgical_completes_move_to_new_corporate_headqua/</loc>
		<lastmod>2018-07-04T15:17:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/914adnymox_obtains_15_million_equity_financing_commi/</loc>
		<lastmod>2018-07-04T15:17:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eli-lilly-liver-cancer-treatment-cyramza-meets-primary-endpoint-in-phase-3-reach-2-study-050418-6104910/</loc>
		<lastmod>2018-07-04T15:17:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer-ose-immunotherapeutics-sign-14bn-immuno-oncology-deal-050318-6105435/</loc>
		<lastmod>2018-07-04T15:17:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/124b4provena_saint_joseph_hospital_of_illinois_implements_zolls_auto/</loc>
		<lastmod>2018-07-04T15:17:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/30482northfields_bla_for_red_blood_cell_drug_granted_fda_priority_rev/</loc>
		<lastmod>2018-07-04T15:17:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/25496mylans_subsidiary_wins_fda_approval_for_generic_zerit_cap/</loc>
		<lastmod>2018-07-04T15:17:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/king_pharmaceuticals_initiates_phase_ii_pain_trial_311208/</loc>
		<lastmod>2018-07-04T15:17:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/johnson_johnson_completes_tender_offer_for_omrix_311208/</loc>
		<lastmod>2018-07-04T15:17:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_acquires_rights_to_alphavaxs_cmv_vaccine_candidate_311208/</loc>
		<lastmod>2018-07-04T15:17:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ema-to-review-cemiplimab-for-treatment-of-advanced-cutaneous-squamous-cell-carcinoma-040418-6103623/</loc>
		<lastmod>2018-07-04T15:17:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-allogene-strike-deal-to-develop-cancer-cell-therapies-040418-6103475/</loc>
		<lastmod>2018-07-04T15:17:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us-and-european-regulators-accept-astrazenecas-applications-for-cancer-treatments-040418-6103347/</loc>
		<lastmod>2018-07-04T15:17:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sosei_re_acquires_rights_to_pain_drug_from_mundipharma_311208/</loc>
		<lastmod>2018-07-04T15:17:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allergan_wins_fda_approval_for_eyelashes_drug_311208/</loc>
		<lastmod>2018-07-04T15:17:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e3498perrigo_wins_fda_approval_for_generic_advil_pm_ta/</loc>
		<lastmod>2018-07-04T15:17:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-rejects-alkermes-nda-for-antidepressant-drug-030418-6102339/</loc>
		<lastmod>2018-07-04T15:17:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dr-reddys-promius-pharma-files-nda-for-migraine-candidate-with-fda-020418-6101032/</loc>
		<lastmod>2018-07-04T15:17:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/304b7intercell_initiates_phase_ii_pseudomonas_aeruginosa_vaccine_/</loc>
		<lastmod>2018-07-04T15:17:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/794a4yissums_ceo_to_/</loc>
		<lastmod>2018-07-04T15:17:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/774b8rosetta_genomics_introduces_new_cancer/</loc>
		<lastmod>2018-07-04T15:17:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/myokardia-begins-phase-2-hcm-trial-of-mavacamten-030418-6101893/</loc>
		<lastmod>2018-07-04T15:17:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a04b4icads_secondlook_digital_with_agfas_solutions_now_available_in_e/</loc>
		<lastmod>2018-07-04T15:17:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ferring_wins_fda_approval_for_prostate_cancer_drug_301208/</loc>
		<lastmod>2018-07-04T15:17:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sembiosys_and_mannkind_sign_option_agreement_for_plant_produced_insulin_301208/</loc>
		<lastmod>2018-07-04T15:17:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nicox_announces_results_from_phase_iia_copd_study_301208/</loc>
		<lastmod>2018-07-04T15:17:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alnylam_files_ind_application_for_liver_cancer_drug_301208/</loc>
		<lastmod>2018-07-04T15:17:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sellas-neuvax-herceptin-combination-treatment-shows-significant-effect-in-breast-cancer-trial-030418-6101936/</loc>
		<lastmod>2018-07-04T15:17:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/compugen-medimmune-to-develop-bi-specific-and-multi-specific-antibody-products-030418-6101774/</loc>
		<lastmod>2018-07-04T15:17:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizers-tafamidis-meets-primary-endpoint-in-phase-3-transthyretin-cardiomyopathy-study-020418-6100817/</loc>
		<lastmod>2018-07-04T15:17:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amag_pharmaceuticals_receives_fda_complete_response_letter_for_anemia_drug_301208/</loc>
		<lastmod>2018-07-04T15:17:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celgenes_vidaza_wins_marketing_approval_for_treatment_of_mds_and_aml_301208/</loc>
		<lastmod>2018-07-04T15:17:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china_biologic_obtains_16m_sales_order_from_india_301208/</loc>
		<lastmod>2018-07-04T15:17:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/insite_reports_positive_recommendation_for_bausch_lombs_conjunctivitis_drug_301208/</loc>
		<lastmod>2018-07-04T15:17:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d64bfcelera_and_abbott_revise_strategic_all/</loc>
		<lastmod>2018-07-04T15:17:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-expands-approval-for-amgens-blincyto-for-certain-type-of-leukemia-020418-6100663/</loc>
		<lastmod>2018-07-04T15:17:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medicinovas-mn-001-meets-primary-end-point-in-nash-nafld-study-020418-6100588/</loc>
		<lastmod>2018-07-04T15:17:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/51480canfite_completes_enrollment_for_phase_iib_rheumatoid_arthritis_/</loc>
		<lastmod>2018-07-04T15:17:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ortho_clinical_diagnostics_wins_clearance_for_new_immunoassay_system_301208/</loc>
		<lastmod>2018-07-04T15:17:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actinium-pharmaceuticals-astellas-collaborate-on-awe-platform-technology-290318-6099397/</loc>
		<lastmod>2018-07-04T15:17:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bluebird-celgene-to-co-develop-anti-bcma-car-t-cell-therapy-for-myeloma-290318-6099199/</loc>
		<lastmod>2018-07-04T15:17:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/984aburigen_amends_licensing_agreement_with/</loc>
		<lastmod>2018-07-04T15:17:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/154bapediatrix_to_change_name_to_mednax_by_end_of/</loc>
		<lastmod>2018-07-04T15:17:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-considers-bidding-for-biopharmaceutical-firm-shire-290318-6099258/</loc>
		<lastmod>2018-07-04T15:17:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_aventis_and_novozymes_collaborate_to_develop_new_antibiotic_291208/</loc>
		<lastmod>2018-07-04T15:17:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ligand_completes_acquisition_of_pharmacopeia_291208/</loc>
		<lastmod>2018-07-04T15:17:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/004b7novarx_opens_phase_iii_lung_cancer_vaccine_trial_in_s/</loc>
		<lastmod>2018-07-04T15:17:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b49flifecycle_pharma_initiates_enrollment_in_phase_iii_kidney_transplant_/</loc>
		<lastmod>2018-07-04T15:17:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china_sky_one_medical_wins_chinese_production_approval_for_four_new_drugs_291208/</loc>
		<lastmod>2018-07-04T15:17:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daiichi-sankyos-ds-8201-gets-sakigake-designation-for-gastric-cancer-in-japan-280318-6097789/</loc>
		<lastmod>2018-07-04T15:17:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/protagonist-therapeutics-stops-ulcerative-colitis-trial-of-ptg-100-280318-6097762/</loc>
		<lastmod>2018-07-04T15:17:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fennecs-pedmark-gets-fda-breakthrough-therapy-status-to-prevent-cisplatin-related-ototoxicity-in-pediatric-patients-280318-6097661/</loc>
		<lastmod>2018-07-04T15:17:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytokinetics_retains_rights_to_two_cancer_drug_candidates_291208/</loc>
		<lastmod>2018-07-04T15:17:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dr_reddys_resolves_patent_litigation_with_schering_and_sepracor_291208/</loc>
		<lastmod>2018-07-04T15:17:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/generex_wins_lebanese_approval_for_oral_insulin_spray_product_291208/</loc>
		<lastmod>2018-07-04T15:17:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-to-acquire-novartis-stake-in-consumer-healthcare-jv-for-13bn-270318-6096623/</loc>
		<lastmod>2018-07-04T15:17:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chinese-biotech-company-adagene-raises-50m-in-new-funding-round-270318-6096343/</loc>
		<lastmod>2018-07-04T15:17:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seattle-genetics-astellas-get-fda-breakthrough-therapy-designation-for-enfortumab-vedotin-locally-advanced-or-metastatic-urothelial-cancer-270318-6096324/</loc>
		<lastmod>2018-07-04T15:17:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6049anihon_kohden_acquires_neurotr/</loc>
		<lastmod>2018-07-04T15:17:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nabi_reaches_agreement_with_fda_for_phase_iii_protocol_of_nicotine_vaccine_291208/</loc>
		<lastmod>2018-07-04T15:17:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novadel_wins_fda_approval_for_insomnia_drug_291208/</loc>
		<lastmod>2018-07-04T15:18:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/paladin_labs_acquires_virexx_medical_291208/</loc>
		<lastmod>2018-07-04T15:18:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ablynxs-vobarilizumab-fails-to-meet-primary-endpoint-in-phase-ii-lupus-study-270318-6096242/</loc>
		<lastmod>2018-07-04T15:18:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen_submits_biologics_license_application_for_fda_261208/</loc>
		<lastmod>2018-07-04T15:18:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arqule_provides_update_on_early_stage_product_pipeline_261208/</loc>
		<lastmod>2018-07-04T15:18:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca_and_map_pharmaceuticals_collaborate_for_unit_dose_budesonide_261208/</loc>
		<lastmod>2018-07-04T15:18:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/soligenix-gets-orphan-drug-designation-from-european-commission-for-rivax-to-prevent-ricin-poisoning-260318-6094935/</loc>
		<lastmod>2018-07-04T15:18:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mitsubishi-tanabe-hitachi-to-use-ai-for-improving-efficiency-of-clinical-trials-260318-6094881/</loc>
		<lastmod>2018-07-04T15:18:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fe49fimuc_reports_promising_data_from_phase_i_brain_cancer_/</loc>
		<lastmod>2018-07-04T15:18:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/drais_and_diatos_partner_to_develop_new_cancer_drug_261208/</loc>
		<lastmod>2018-07-04T15:18:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd490ajinomoto_and_astellas_announce_approval_for_new_indication_of_diabetes/</loc>
		<lastmod>2018-07-04T15:18:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a74bcchina_biologic_obtains_16_million_sales_order_from_/</loc>
		<lastmod>2018-07-04T15:18:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_accepts_neurogesxs_nda_for_post_herpetic_neuralgia_treatment_261208/</loc>
		<lastmod>2018-07-04T15:18:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-lung-cancer-combination-drug-shows-significant-survival-benefit-in-phase-iii-study-260318-6094808/</loc>
		<lastmod>2018-07-04T15:18:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizers-smoking-cessation-drug-fails-to-meet-primary-endpoint-in-phase-4-study-260318-6095457/</loc>
		<lastmod>2018-07-04T15:18:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/deinove-to-acquire-anti-infective-program-from-redx-pharma-230318-6093494/</loc>
		<lastmod>2018-07-04T15:18:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4748edaiichi_sankyo_forms_alliance_with_the_kitasato_inst/</loc>
		<lastmod>2018-07-04T15:18:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c483volcano_to_acquire_axsun_technol/</loc>
		<lastmod>2018-07-04T15:18:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/forest_laboratories_and_pierre_fabre_partner_to_develop_depression_drug_261208/</loc>
		<lastmod>2018-07-04T15:18:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e54a7aetna_and_baycare_health_system_sign_multiyear_con/</loc>
		<lastmod>2018-07-04T15:18:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/474a7bristolmyers_to_pay_11_million_as_settlement_charges_in_plavix/</loc>
		<lastmod>2018-07-04T15:18:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-expands-approval-for-novartis-tasigna-to-treat-rare-form-of-leukemia-in-children-230318-6093235/</loc>
		<lastmod>2018-07-04T15:18:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbvie-not-to-seek-accelerated-approval-for-rova-t-after-phase-2-failure-230318-6093198/</loc>
		<lastmod>2018-07-04T15:18:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/indias-sun-pharma-gets-fda-nod-for-ilumya-to-treat-moderate-to-severe-plaque-psoriasis-220318-6092222/</loc>
		<lastmod>2018-07-04T15:18:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/47482king_pharmaceuticals_exercises_option_to_license_acuras_fourth_opioid_pr/</loc>
		<lastmod>2018-07-04T15:18:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_wins_fda_approval_for_new_indication_of_gleevec_261208/</loc>
		<lastmod>2018-07-04T15:18:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b8495medtronic_purchases_influent_medicals_repose_product/</loc>
		<lastmod>2018-07-04T15:18:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9049esorin_group_resolves_lawsuit_with_ats_me/</loc>
		<lastmod>2018-07-04T15:18:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/97481biocryst_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:18:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/helsinn-group-to-buy-worldwide-rights-of-valchlorledaga-from-actelion-pharmaceuticals-220318-6091845/</loc>
		<lastmod>2018-07-04T15:18:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regeneron-alnylam-to-collaborate-on-new-treatments-for-nash-220318-6091804/</loc>
		<lastmod>2018-07-04T15:18:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/reckitt-benckiser-drops-plans-to-buy-pfizer-consumer-healthcare-business-220318-6091576/</loc>
		<lastmod>2018-07-04T15:18:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/074bfemisphere_technologies_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:18:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/96497teva_launches_new_needle_for_copaxone_prefilled_sy/</loc>
		<lastmod>2018-07-04T15:18:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/794b3trinity_biotech_files_510k_for_new_coagulation_ana/</loc>
		<lastmod>2018-07-04T15:18:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f7499lab21_secures_gbp22_million_in_equity_fina/</loc>
		<lastmod>2018-07-04T15:18:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regen_biologics_wins_fda_clearance_for_new_collagen_scaffold_device_261208/</loc>
		<lastmod>2018-07-04T15:18:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/prothena-celgene-collaborate-to-develop-new-therapies-for-neurodegenerative-diseases-210318-6090292/</loc>
		<lastmod>2018-07-04T15:18:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-begins-phase-3-trial-of-benlysta-rituximab-combo-in-systemic-lupus-erythematosus-210318-6090217/</loc>
		<lastmod>2018-07-04T15:18:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cipher-pharmaceuticals-to-acquire-canadian-business-portfolio-of-cardiome-pharma-210318-6090250/</loc>
		<lastmod>2018-07-04T15:18:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sangamo_biosciences_signs_licensing_agreement_with_pfizer_261208/</loc>
		<lastmod>2018-07-04T15:18:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda_initiates_phase_iii_study_of_obesity_drug_261208/</loc>
		<lastmod>2018-07-04T15:18:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tianyin_obtains_production_license_for_generic_constipation_drug_261208/</loc>
		<lastmod>2018-07-04T15:18:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/474b5nwbt_reports_promising_data_from_phase_iii_ovarian_cancer_/</loc>
		<lastmod>2018-07-04T15:18:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-seattle-genetics-adcetris-for-treatment-of-hodgkin-lymphoma-210318-6090023/</loc>
		<lastmod>2018-07-04T15:18:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/non-antibiotic-drugs-could-affect-gut-bacteria-says-study-200318-6088978/</loc>
		<lastmod>2018-07-04T15:18:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arenas-ulcerative-colitis-treatment-etrasimod-shows-significant-effect-in-phase-2-oasis-trial-200318-6088740/</loc>
		<lastmod>2018-07-04T15:18:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/topigen_to_advance_clinical_development_of_new_copd_drug_261208/</loc>
		<lastmod>2018-07-04T15:18:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-new-indication-of-pfizer-and-astellas-xtandi-200318-6088632/</loc>
		<lastmod>2018-07-04T15:18:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/herons-pain-drug-succeeds-in-phase-3-bunionectomy-and-hernia-repair-trials-200318-6088474/</loc>
		<lastmod>2018-07-04T15:18:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bavarian-nordic-partners-with-us-dod-to-develop-vaccine-for-encephalitis-virus-190318-6087170/</loc>
		<lastmod>2018-07-04T15:18:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4e4b7astrazeneca_receives_fda_complete_response_letter_for_seroqu/</loc>
		<lastmod>2018-07-04T15:18:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/transmolecular_wins_orphan_designation_for_melanoma_drug_261208/</loc>
		<lastmod>2018-07-04T15:18:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/harrington_hospital_signs_management_agreement_with_hubbard_hospitals_261208/</loc>
		<lastmod>2018-07-04T15:18:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/48499teva_wins_approval_for_generic_seroquel_ta/</loc>
		<lastmod>2018-07-04T15:18:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c486thermage_completes_acquisition_of_reliant_technol/</loc>
		<lastmod>2018-07-04T15:18:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-hizentra-to-treat-chronic-inflammatory-demyelinating-polyneuropathy-190318-6087253/</loc>
		<lastmod>2018-07-04T15:18:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lundbeck-to-acquire-swiss-biopharma-firm-prexton-for-up-to-905m-190318-6086993/</loc>
		<lastmod>2018-07-04T15:18:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alexions-rare-blood-disorder-treatment-alxn121-succeeds-in-phase-3-study-160318-6085720/</loc>
		<lastmod>2018-07-04T15:18:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zymeworks-takes-second-drug-into-trials-in-her2-expressing-cancers-6085614/</loc>
		<lastmod>2018-07-04T15:18:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a14b1proton_laboratories_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:18:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/984aeonyx_pharmaceuticals_names_new_executive_vice_president_an/</loc>
		<lastmod>2018-07-04T15:18:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/884besqi_diagnostics_raises_c3_million_in_fina/</loc>
		<lastmod>2018-07-04T15:18:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac485medicinova_plans_to_acquire_a/</loc>
		<lastmod>2018-07-04T15:18:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/destiny-pharma-gets-fda-fast-track-designation-for-exeporfinium-chloride-to-prevent-post-surgical-staphylococcal-infections-160318-6085567/</loc>
		<lastmod>2018-07-04T15:18:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ed489neurogen_to_divest_certain_noncore_assets_for_225_mi/</loc>
		<lastmod>2018-07-04T15:18:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/flagship-pioneering-supports-foghorn-therapeutics-with-50m-initial-capital-150318-6084040/</loc>
		<lastmod>2018-07-04T15:18:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/phanes-partners-with-crownbio-to-develop-oncology-drugs-150318-6084029/</loc>
		<lastmod>2018-07-04T15:18:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fe493teva_completes_acquisition_of_barr_pharmaceutic/</loc>
		<lastmod>2018-07-04T15:18:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/294b4dr_reddys_resolves_clarinex_patent_litigation_with_schering_and_sep/</loc>
		<lastmod>2018-07-04T15:18:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/844a4covidien_to_relocate_principal_executive_office_to_ir/</loc>
		<lastmod>2018-07-04T15:18:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/proteostasis-therapeutics-gets-fda-orphan-drug-designation-for-pti-428-to-treat-cystic-fibrosis-150318-6084072/</loc>
		<lastmod>2018-07-04T15:18:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0a4basymmetrix_names_new_chief_scientific_of/</loc>
		<lastmod>2018-07-04T15:18:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cb4b9avi_biopharma_wins_clearance_for_ind_applications_of_antiviral_/</loc>
		<lastmod>2018-07-04T15:18:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/solid-biosciences-places-clinical-hold-on-dmd-gene-therapy-sgt-001-150318-6083600/</loc>
		<lastmod>2018-07-04T15:18:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbvies-elagolix-succeeds-in-second-phase-3-uterine-fibroid-study-130318-6082465/</loc>
		<lastmod>2018-07-04T15:18:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kiadis-raises-234m-to-develop-immunotherapy-for-gvhd-140318-6082157/</loc>
		<lastmod>2018-07-04T15:18:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0249cgsk_and_archemix_form_research_alliance_for_antiinflammatory_/</loc>
		<lastmod>2018-07-04T15:18:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5e48fvia_pharmaceuticals_licenses_new_drug_candidates_from_/</loc>
		<lastmod>2018-07-04T15:18:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3d489bmp_sunstone_to_acquire_50_stake_in_shengda_pharmaceutic/</loc>
		<lastmod>2018-07-04T15:18:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df489breckenridge_signs_agreement_with_helm_to_develop_anda_for_asthma/</loc>
		<lastmod>2018-07-04T15:18:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5f49dwarner_chilcott_files_lawsuits_against_mutual_pharmaceutical_mylan_and_/</loc>
		<lastmod>2018-07-04T15:18:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/de4b0gsk_and_theravance_present_positive_results_from_phase_iib_copd_/</loc>
		<lastmod>2018-07-04T15:18:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/84496morphotek_signs_research_agreement_with_university_of_pennsyl/</loc>
		<lastmod>2018-07-04T15:18:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/07493warner_chilcott_and_barr_resolve_femcon_fe_patent_litig/</loc>
		<lastmod>2018-07-04T15:18:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/avigen_sells_early_stage_blood_coagulation_drug_to_baxter_241208/</loc>
		<lastmod>2018-07-04T15:18:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-mercks-keytruda-for-cervical-cancer-140318-6081924/</loc>
		<lastmod>2018-07-04T15:18:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-upholds-decision-on-generic-version-of-gsks-asthmacopd-inhaler-advair-diskus-130318-6080579/</loc>
		<lastmod>2018-07-04T15:18:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sarepta-to-seek-accelerated-fda-approval-for-dmd-drug-golodirsen-120318-6080503/</loc>
		<lastmod>2018-07-04T15:18:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/94488sciclone_initiates_enrollment_in_phase_ii_oral_mucositis_/</loc>
		<lastmod>2018-07-04T15:18:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/05484flamel_technologies_signs_new_micropump_and_medusa_contra/</loc>
		<lastmod>2018-07-04T15:18:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssens-new-analysis-shows-invokana-reduces-risk-of-heart-failure-130318-6080590/</loc>
		<lastmod>2018-07-04T15:18:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogen-to-acquire-pfizers-schizophrenia-drug-for-up-to-590m-130318-6080316/</loc>
		<lastmod>2018-07-04T15:18:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/covance-launches-new-global-unit-for-biologic-drug-development-120318-6079161/</loc>
		<lastmod>2018-07-04T15:18:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/504b6pfizer_names_new_senior_vice_president_of_litig/</loc>
		<lastmod>2018-07-04T15:18:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/33484epix_pharmaceuticals_announces_fda_approval_of_vasov/</loc>
		<lastmod>2018-07-04T15:18:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/47498paladin_and_prostrakan_sign_licensing_and_distribution_agre/</loc>
		<lastmod>2018-07-04T15:18:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/46492kalobios_secures_additional_12_million_in_series_d_fina/</loc>
		<lastmod>2018-07-04T15:18:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/crystalgenomicss_phase_iia_osteoarthritis_study_meets_endpoint_231208/</loc>
		<lastmod>2018-07-04T15:18:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cd482biovail_signs_supply_agreement_with_sanofi_aventis_for_depression/</loc>
		<lastmod>2018-07-04T15:18:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ferring_wins_european_positive_opinion_for_prostate_cancer_drug_231208/</loc>
		<lastmod>2018-07-04T15:18:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/prevail-therapeutics-secures-75m-financing-to-advance-development-of-gene-therapies-for-parkinsons-disease-120318-6079171/</loc>
		<lastmod>2018-07-04T15:18:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regenerons-anti-cholesterol-drug-praluent-reduces-death-risk-12-0318-6079044/</loc>
		<lastmod>2018-07-04T15:18:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-gets-positive-response-from-fda-panel-for-ulcerative-colitis-treatment-xeljanz-090318-6077812/</loc>
		<lastmod>2018-07-04T15:18:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/974b5abiomed_appoint/</loc>
		<lastmod>2018-07-04T15:18:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4e4b0st_jude_medical_acquires_medigu/</loc>
		<lastmod>2018-07-04T15:18:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/914a8nps_pharmaceuticals_initiates_phase_iii_hypoparathyroidism_/</loc>
		<lastmod>2018-07-04T15:18:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5b4a9galapagos_expands_alliance_with_glaxosmith/</loc>
		<lastmod>2018-07-04T15:18:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/68493takeda_wins_approval_for_additional_indication_of_diabetes/</loc>
		<lastmod>2018-07-04T15:18:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/204a5xgen_to_begin_marketing_of_acetazolamide_for_injectio/</loc>
		<lastmod>2018-07-04T15:18:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-gets-eu-approval-for-labelling-update-to-relvar-ellipta-in-patients-with-asthma-090318-6077598/</loc>
		<lastmod>2018-07-04T15:18:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/summit-begins-enrolment-for-new-group-for-phase-2-dmd-trial-of-ezutromid-090318-6077343/</loc>
		<lastmod>2018-07-04T15:18:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec-sanofi-to-join-forces-for-research-on-infectious-disease-drugs-090318-6077302/</loc>
		<lastmod>2018-07-04T15:18:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8d494medistem_files_ind_application_for_conducting_clinical_studies_in_isc/</loc>
		<lastmod>2018-07-04T15:18:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genmab_amends_cancer_drug_co_promotion_agreement_with_gsk_231208/</loc>
		<lastmod>2018-07-04T15:18:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/564b3neuralstem_files_fda_application_for_als_stem_cell_/</loc>
		<lastmod>2018-07-04T15:18:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eisai-merck-collaborate-to-develop-and-commercialize-cancer-drug-lenvima-080318-6076549/</loc>
		<lastmod>2018-07-04T15:18:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jw-therapeutics-secures-90m-in-new-funding-080318-6076306/</loc>
		<lastmod>2018-07-04T15:18:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/47488dynavax_announces_termination_of_partnership_with_merck__co/</loc>
		<lastmod>2018-07-04T15:18:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/78481marshall_edwards_announces_resignation_of_board_m/</loc>
		<lastmod>2018-07-04T15:18:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ligand-licenses-glucagon-receptor-antagonist-program-to-roivant-sciences-080318-6076196/</loc>
		<lastmod>2018-07-04T15:18:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/74480us_federal_trade_commission_clears_tevas_acquisition_of/</loc>
		<lastmod>2018-07-04T15:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c649carpida_reports_positive_results_from_phase_ii_trial_with_oral_icl/</loc>
		<lastmod>2018-07-04T15:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bb4a4novocell_enters_into_nonexclusive_drug_discovery_collaboration_with_p/</loc>
		<lastmod>2018-07-04T15:19:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c149dmedtronic_acquires_remaining_shares_of_cryocath_technol/</loc>
		<lastmod>2018-07-04T15:19:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/king_pharmaceuticals_files_nda_for_new_cardiac_imaging_agent_231208/</loc>
		<lastmod>2018-07-04T15:19:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-to-launch-more-virtual-clinical-trials-in-collaboration-with-science-37-080318-6075972/</loc>
		<lastmod>2018-07-04T15:19:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/caladrius-buys-license-to-cell-therapy-program-for-refractory-angina-treatment-070318-6074741/</loc>
		<lastmod>2018-07-04T15:19:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-lilly-expand-heart-failure-program-for-jardiance-with-new-clinical-trials-070318-6074721/</loc>
		<lastmod>2018-07-04T15:19:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d2498alung_technologies_appoints_ne/</loc>
		<lastmod>2018-07-04T15:19:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7c487medipurpose_names_domrex_pharma_as_distributor_of_surgilance_safety_l/</loc>
		<lastmod>2018-07-04T15:19:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d24b0celtic_therapeutics_announces_first_closing_and_management_ch/</loc>
		<lastmod>2018-07-04T15:19:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e64bfsun_pharmaceutical_extends_tender_offer_for/</loc>
		<lastmod>2018-07-04T15:19:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2d496johnson__johnson_extends_tender_offer_for_omrix_biopharmaceut/</loc>
		<lastmod>2018-07-04T15:19:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristol-myers-secures-fda-approval-for-new-dosing-of-cancer-drug-opdivo-070318-6074509/</loc>
		<lastmod>2018-07-04T15:19:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ema-to-review-astrazenecas-forxiga-for-type-1-diabetes-060318-6073441/</loc>
		<lastmod>2018-07-04T15:19:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vividion-therapeutics-celgene-collaborate-to-discover-therapies-against-transformative-first-in-class-targets-060318-6073418/</loc>
		<lastmod>2018-07-04T15:19:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c548aamgen_submits_biologics_license_application_for_fda_approval_of_deno/</loc>
		<lastmod>2018-07-04T15:19:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ligand_signs_licensing_agreement_with_glaxosmithkline_231208/</loc>
		<lastmod>2018-07-04T15:19:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4649bst_jude_medical_acquires_radi_medical_systems_for_250_mi/</loc>
		<lastmod>2018-07-04T15:19:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e04b2progen_pharmaceuticals_and_avexa_agree_to_/</loc>
		<lastmod>2018-07-04T15:19:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mannkind_reports_results_from_two_phase_iii_diabetes_trials_231208/</loc>
		<lastmod>2018-07-04T15:19:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dermira-to-discontinue-acne-vulgaris-drug-after-failure-in-phase-3-program-060318-6073153/</loc>
		<lastmod>2018-07-04T15:19:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/researchers-develop-new-way-to-develop-drug-producing-bacteria-060318-6073982/</loc>
		<lastmod>2018-07-04T15:19:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofis-dupixent-to-be-reviewed-by-fda-for-severe-asthma-050318-6072131/</loc>
		<lastmod>2018-07-04T15:19:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/memory_pharmaceuticals_initiates_enrollment_in_asthma_trial_231208/</loc>
		<lastmod>2018-07-04T15:19:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_acquires_manufacturing_rights_to_cancer_drug_from_oncothyreon_231208/</loc>
		<lastmod>2018-07-04T15:19:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neuralstem_files_ind_application_to_initiate_als_trial_231208/</loc>
		<lastmod>2018-07-04T15:19:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_and_celldex_to_amend_act_iii_study_of_cancer_drug_231208/</loc>
		<lastmod>2018-07-04T15:19:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-to-launch-two-new-hiv-combination-treatments-in-us-050318-6072128/</loc>
		<lastmod>2018-07-04T15:19:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ptc_therapeutics_initiates_two_cancer_trials_231208/</loc>
		<lastmod>2018-07-04T15:19:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/leo-pharma-sells-major-product-portfolio-to-karo-pharma-for-260m-020318-6070774/</loc>
		<lastmod>2018-07-04T15:19:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rubius-raises-100m-funding-to-develop-red-cell-therapeutics-010318-6070521/</loc>
		<lastmod>2018-07-04T15:19:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-to-develop-botox-biosimilar-in-partnership-with-revance-010318-6069256/</loc>
		<lastmod>2018-07-04T15:19:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rhei_pharmaceuticals_wins_chinese_approval_for_scar_treatment_product_231208/</loc>
		<lastmod>2018-07-04T15:19:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/stemcells_wins_fda_approval_to_initiate_phase_i_pmd_trial_231208/</loc>
		<lastmod>2018-07-04T15:19:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sucampo_initiates_dosing_in_peripheral_arterial_disease_trial_231208/</loc>
		<lastmod>2018-07-04T15:19:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/targanta_cuts_75_jobs_231208/</loc>
		<lastmod>2018-07-04T15:19:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3348ebeacon_expands_infrastructure_agreement_with_pharmaceutical_firm/</loc>
		<lastmod>2018-07-04T15:19:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/covance-signs-strategic-technology-agreement-with-gsk-010318-6069500/</loc>
		<lastmod>2018-07-04T15:19:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sorrento-gets-fda-nod-for-non-opioid-ztlido-18-to-relieve-post-shingles-pain-010318-6069396/</loc>
		<lastmod>2018-07-04T15:19:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-to-launch-new-us-based-biotech-company-viela-bio-010318-6069107/</loc>
		<lastmod>2018-07-04T15:19:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/minsurg_and_odc_settle_patent_litigation_with_nutech_and_nufix_221208/</loc>
		<lastmod>2018-07-04T15:19:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cognition_reports_positive_memory_data_from_multiple_sclerosis_trial_221208/</loc>
		<lastmod>2018-07-04T15:19:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-rejects-celgenes-ind-for-relapsing-multiple-sclerosis-drug-ozanimod-280218-6068170/</loc>
		<lastmod>2018-07-04T15:19:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/valeant-kaken-sign-license-agreement-for-psoriasis-candidate-280218-6067945/</loc>
		<lastmod>2018-07-04T15:19:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/senti-biosciences-secures-53m-funding-to-advance-therapeutic-design-platform-280218-6068061/</loc>
		<lastmod>2018-07-04T15:19:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/auxilium_and_pfizer_partner_in_drug_development_221208/</loc>
		<lastmod>2018-07-04T15:19:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/addex_initiates_phase_iib_migraine_trial_221208/</loc>
		<lastmod>2018-07-04T15:19:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_to_acquire_ibis_biosciences_221208/</loc>
		<lastmod>2018-07-04T15:19:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medivation_completes_enrollment_in_phase_i_ii_prostate_cancer_trial_191208/</loc>
		<lastmod>2018-07-04T15:19:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-hemophilia-drug-hemlibra-secures-european-approval-280218-6067769/</loc>
		<lastmod>2018-07-04T15:19:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nabi_signs_cooperative_rd_agreement_with_usu_and_hjf_191208/</loc>
		<lastmod>2018-07-04T15:19:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pressure_biosciences_and_jcvi_sign_collaboration_agreement_191208/</loc>
		<lastmod>2018-07-04T15:19:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vlst_and_novo_nordisk_sign_collaboration_agreement_191208/</loc>
		<lastmod>2018-07-04T15:19:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emergent-valneva-begin-phase-1-trial-for-zika-vaccine-candidate-270218-6066616/</loc>
		<lastmod>2018-07-04T15:19:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shionogi-gets-fdas-nda-and-emas-maa-acceptances-for-thrombocytopenia-treatment-lusutrombopag-270218-6066726/</loc>
		<lastmod>2018-07-04T15:19:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zoll_medical_wins_fda_clearance_to_market_new_defibrillator_with_wi_fi_option_191208/</loc>
		<lastmod>2018-07-04T15:19:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/remedent_restructures_otc_division_191208/</loc>
		<lastmod>2018-07-04T15:19:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-expands-approval-of-lillys-breast-cancer-drug-verzenio-270218-6066469/</loc>
		<lastmod>2018-07-04T15:19:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/destiny-pharma-gets-fda-ind-approval-for-novel-anti-infective-drug-xf-73-270218-6066901/</loc>
		<lastmod>2018-07-04T15:19:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristol_myers_squibb_wins_canadian_approval_for_lower_dose_leukemia_drug_191208/</loc>
		<lastmod>2018-07-04T15:19:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biovitrum_and_amgen_close_product_acquisition_deal_191208/</loc>
		<lastmod>2018-07-04T15:19:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/anesivas_phase_iii_pain_trial_meets_endpoint_191208/</loc>
		<lastmod>2018-07-04T15:19:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shield-receives-chmp-positive-opinion-for-feraccru-to-treat-iron-deficiency-in-adults-260218-6065528/</loc>
		<lastmod>2018-07-04T15:19:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b2495amarin_establishes_new_rd_facility_in_mystic_connec/</loc>
		<lastmod>2018-07-04T15:19:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/394b9pdl_biopharma_names_new_vice_president_an/</loc>
		<lastmod>2018-07-04T15:19:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/974b4baxter_wins_european_positive_opinion_for_pandemic_flu_vaccin/</loc>
		<lastmod>2018-07-04T15:19:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/25494memory_pharmaceuticals_initiates_enrollment_in_phase_iia_asthma_/</loc>
		<lastmod>2018-07-04T15:19:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ba4bfsucampo_initiates_dosing_in_phase_i_peripheral_arterial_disease_/</loc>
		<lastmod>2018-07-04T15:19:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/094betomotherapy_reduces_workforce_b/</loc>
		<lastmod>2018-07-04T15:19:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fb49bresolvyx_initiates_phase_iii_dry_eye_/</loc>
		<lastmod>2018-07-04T15:19:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9e4acconvatec_and_boehringer_technologies_sign_licensing_agreemen/</loc>
		<lastmod>2018-07-04T15:19:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/99494arete_reports_positive_data_from_phase_i_metabolic_syndrome_/</loc>
		<lastmod>2018-07-04T15:19:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/314a5idm_pharma_wins_european_positive_opinion_for_osteosarcoma/</loc>
		<lastmod>2018-07-04T15:19:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2f4aedaiichi_and_lillys_oral_antiplatelet_drug_wins_european_positive_op/</loc>
		<lastmod>2018-07-04T15:19:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/344b1ppd_to_begin_contract_research_operations_in_ir/</loc>
		<lastmod>2018-07-04T15:19:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db4acwyeth_pharmaceuticals_acquires_th/</loc>
		<lastmod>2018-07-04T15:19:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a84b5cumberland_wins_approval_for_updated_labeling_of_acetadote_inje/</loc>
		<lastmod>2018-07-04T15:19:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/854b7mannkind_reports_topline_results_from_two_phase_iii_diabetes_t/</loc>
		<lastmod>2018-07-04T15:19:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cd4bdaetna_to_axe_1000/</loc>
		<lastmod>2018-07-04T15:19:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c04b6sbio_forms_research_collaboration_with_tan_tock_seng_hos/</loc>
		<lastmod>2018-07-04T15:19:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ea482kci_files_patent_infringement_suit_against_convatec_and_boehr/</loc>
		<lastmod>2018-07-04T15:19:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/25485neogenix_oncology_names_new_vice_cha/</loc>
		<lastmod>2018-07-04T15:19:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e448fjazz_pharmaceuticals_wins_us_patent_for_onceaday_luv/</loc>
		<lastmod>2018-07-04T15:19:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/da495champions_biotechnology_and_centocor_partner_in_cancer_drug_evalu/</loc>
		<lastmod>2018-07-04T15:19:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/634abalsius_wins_threeyear_gpo_contract_from_nov/</loc>
		<lastmod>2018-07-04T15:19:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6e4bfadvanced_cell_technology_signs_licensing_agreement_with_transition_hol/</loc>
		<lastmod>2018-07-04T15:19:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fc48ast_jude_medical_renews_development_contract_with_/</loc>
		<lastmod>2018-07-04T15:19:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ef48ctopotarget_initiates_patient_recruitment_in_lymphoma_tr/</loc>
		<lastmod>2018-07-04T15:19:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/68499dsm_biologics_and_crucell_sign_licensing_agreement_wit/</loc>
		<lastmod>2018-07-04T15:19:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5749bgalapagos_extends_collaboration_agreement_with_/</loc>
		<lastmod>2018-07-04T15:19:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/15495vistagen_and_warf_sign_licensing_agre/</loc>
		<lastmod>2018-07-04T15:19:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4749earyx_reports_positive_data_from_phase_iib_atrial_fibrillation_/</loc>
		<lastmod>2018-07-04T15:19:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qrxpharma_initiates_comparative_study_for_pain_therapy_181208/</loc>
		<lastmod>2018-07-04T15:19:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pluristem_seeks_german_approval_to_initiate_ischemia_study_181208/</loc>
		<lastmod>2018-07-04T15:19:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/obagi_medical_expands_partnership_with_rohto_pharmaceutical_181208/</loc>
		<lastmod>2018-07-04T15:19:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/epicept_wins_canadian_approval_for_new_leukemia_drug_filing_181208/</loc>
		<lastmod>2018-07-04T15:19:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/entremed_to_cut_60_of_workforce_181208/</loc>
		<lastmod>2018-07-04T15:19:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/diazyme_laboratories_wins_clearance_to_market_new_lithium_test_181208/</loc>
		<lastmod>2018-07-04T15:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celonova_wins_fda_clearance_for_embozene_microspheres_181208/</loc>
		<lastmod>2018-07-04T15:20:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bipar_reports_positive_interim_data_from_phase_ii_breast_cancer_study_181208/</loc>
		<lastmod>2018-07-04T15:20:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amvac_partners_with_taiwanese_research_institutes_to_develop_new_flu_vaccine_181208/</loc>
		<lastmod>2018-07-04T15:20:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abraxis_bioscience_introduces_new_breast_cancer_drug_in_eu_181208/</loc>
		<lastmod>2018-07-04T15:20:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medicago_to_expand_manufacturing_facility_in_quebec_181208/</loc>
		<lastmod>2018-07-04T15:20:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mdrna_wins_tentative_approval_for_generic_osteoporosis_drug_181208/</loc>
		<lastmod>2018-07-04T15:20:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genzyme_wins_fda_approval_for_stem_cell_transplant_drug_181208/</loc>
		<lastmod>2018-07-04T15:20:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celsion_signs_licensing_agreement_with_yakult_honsha_181208/</loc>
		<lastmod>2018-07-04T15:20:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boston_scientific_wins_fda_approval_for_express_sd_renal_stent_system_181208/</loc>
		<lastmod>2018-07-04T15:20:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biodelivery_sciences_resubmits_nda_for_breakthrough_pain_drug_181208/</loc>
		<lastmod>2018-07-04T15:20:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aposense_initiates_phase_ii_molecular_imaging_of_apoptosis_study_181208/</loc>
		<lastmod>2018-07-04T15:20:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_wins_fda_approval_for_dyslipidemia_drug_181208/</loc>
		<lastmod>2018-07-04T15:20:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/36488scheringplough_chooses_citi_as_global_commercial_card_pro/</loc>
		<lastmod>2018-07-04T15:20:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/904b1prime_therapeutics_names_new_chief_marketing_of/</loc>
		<lastmod>2018-07-04T15:20:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca4abalchemia_achieves_milestone_in_generic_fondaparinux_commercializ/</loc>
		<lastmod>2018-07-04T15:20:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/664a5delcath_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:20:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/de49ccadence_reports_positive_topline_results_from_phase_iii_pain_/</loc>
		<lastmod>2018-07-04T15:20:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fe4b5neurobiological_terminates_enrollment_in_stroke_drug_/</loc>
		<lastmod>2018-07-04T15:20:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b7489biopure_files_ind_application_for_phase_ii_leukemia_/</loc>
		<lastmod>2018-07-04T15:20:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d6480covalon_wins_ce_mark_for_biostep_collagen_dres/</loc>
		<lastmod>2018-07-04T15:20:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6c49econcateno_partners_with_merck_to_launch_cozart_products_in_/</loc>
		<lastmod>2018-07-04T15:20:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/594a5lescarden_signs_distribution_agreement_with_ph/</loc>
		<lastmod>2018-07-04T15:20:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c64a3basilea_pharmaceutica_initiates_us_phase_iii_eczema_/</loc>
		<lastmod>2018-07-04T15:20:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/24492kv_pharmaceutical_introduces_enhanced_formulation_of_primacar/</loc>
		<lastmod>2018-07-04T15:20:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b74b5china_medical_technologies_to_divest_hifu_business_to_chen/</loc>
		<lastmod>2018-07-04T15:20:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fe48cdsm_and_crucell_sign_licensing_agreement_wit/</loc>
		<lastmod>2018-07-04T15:20:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4549apeak_surgical_wins_clearance_for_expanded_indications_of_surgery_s/</loc>
		<lastmod>2018-07-04T15:20:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fb494wyeth_licenses_smartopss_enterprise_inventory_optimization_sof/</loc>
		<lastmod>2018-07-04T15:20:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/244accognition_reports_positive_memory_data_from_phase_ii_multiple_sclerosis_/</loc>
		<lastmod>2018-07-04T15:20:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/384b7integramed_subsidiary_to_open_new_location_in_skokie_ill/</loc>
		<lastmod>2018-07-04T15:20:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b4b2kai_pharmaceuticals_initiates_phase_iib_heart_attack_st/</loc>
		<lastmod>2018-07-04T15:20:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/864a5china_aoxing_wins_production_license_for_new_ischemic_stroke/</loc>
		<lastmod>2018-07-04T15:20:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c6489supernus_initiates_phase_iii_epilepsy_/</loc>
		<lastmod>2018-07-04T15:20:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8f494devgen_closes_pharma_div/</loc>
		<lastmod>2018-07-04T15:20:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a34a8lupin_settles_patent_litigation_with_scheringp/</loc>
		<lastmod>2018-07-04T15:20:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d49dcolumbia_laboratories_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:20:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c5492cellumen_introduces_new_cardiac_hypertrophy_/</loc>
		<lastmod>2018-07-04T15:20:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/53484addex_initiates_second_phase_iib_gerd_/</loc>
		<lastmod>2018-07-04T15:20:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/diurnal-secures-patents-for-alkindi-and-chronocort-in-japan-260218-6065429/</loc>
		<lastmod>2018-07-04T15:20:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-kempharms-apadaz-for-short-term-pain-management-260218-6065285/</loc>
		<lastmod>2018-07-04T15:20:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/benevolentai-buys-drug-discovery-and-development-facility-in-cambridge-uk-230218-6064206/</loc>
		<lastmod>2018-07-04T15:20:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1a489cerebrio_and_medlink_international_sign_development_and_marketing_agre/</loc>
		<lastmod>2018-07-04T15:20:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d4491aspenbio_obtains_notice_of_allowance_for_appendicitis_diagnostic_me/</loc>
		<lastmod>2018-07-04T15:20:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce49fabbott_initiates_study_of_xience_v_smaller_stent_s/</loc>
		<lastmod>2018-07-04T15:20:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1f4a2seegene_wins_patent_for_new_haplotyping_techn/</loc>
		<lastmod>2018-07-04T15:20:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e64b9celator_pharmaceuticals_appoints_new_/</loc>
		<lastmod>2018-07-04T15:20:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uk-launches-47m-zika-vaccine-project-230218-6064007/</loc>
		<lastmod>2018-07-04T15:20:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3449dseracare_to_market_raybiotechs_proteomic_pro/</loc>
		<lastmod>2018-07-04T15:20:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kite-sangamo-sign-3bn-gene-editing-deal-for-cancer-230218-6063978/</loc>
		<lastmod>2018-07-04T15:20:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-to-use-emulates-human-emulation-platform-for-drug-discovery-220218-6063091/</loc>
		<lastmod>2018-07-04T15:20:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c44aeaxisshield_and_abbott_sign_development_and_manufacturing_agre/</loc>
		<lastmod>2018-07-04T15:20:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b481crucell_signs_second_licensing_agreement_with_tal/</loc>
		<lastmod>2018-07-04T15:20:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/58484inlog_licenses_laboratory_software_to_saint_maurice_hosp/</loc>
		<lastmod>2018-07-04T15:20:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a64b3paions_partner_lundbeck_initiates_phase_iii_ischemic_stroke_/</loc>
		<lastmod>2018-07-04T15:20:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ee499glaxosmithkline_and_dynavax_form_all/</loc>
		<lastmod>2018-07-04T15:20:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/44486dexcom_names_new_chief_administrative_of/</loc>
		<lastmod>2018-07-04T15:20:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0e486centinel_spine_retains_usdistribution_rights_of_stalif_tt_lumbar_d/</loc>
		<lastmod>2018-07-04T15:20:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d74accombimatrix_launches_new_prostate_cancer/</loc>
		<lastmod>2018-07-04T15:20:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b54a8enigma_signs_term_sheet_for_two_patent_licenses_with_/</loc>
		<lastmod>2018-07-04T15:20:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a3491theratechnologies_closes_collaboration_and_licensing_agreement_with_emd_s/</loc>
		<lastmod>2018-07-04T15:20:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/atum-just-biotherapeutics-collaborate-to-accelerate-drug-discovery-220218-6062911/</loc>
		<lastmod>2018-07-04T15:20:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-acordas-nda-for-inhaled-levodopa-treatment-inbrija-220218-6062832/</loc>
		<lastmod>2018-07-04T15:20:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-to-buy-australian-oncology-firm-viralytics-for-394m-220218-6062663/</loc>
		<lastmod>2018-07-04T15:20:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dd48ctrinity_biotech_launches_new_haemostasis_analyzer_in_e/</loc>
		<lastmod>2018-07-04T15:20:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1249dingen_signs_agreements_with_batterjee_and_progressive_internat/</loc>
		<lastmod>2018-07-04T15:20:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9d49bppd_to_begin_central_lab_operations_in_sing/</loc>
		<lastmod>2018-07-04T15:20:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tetraphase-everest-sign-licensing-deal-for-ciai-drug-eravacycline-in-china-210218-6061504/</loc>
		<lastmod>2018-07-04T15:20:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan-bags-fdas-tentative-approval-for-fixed-dose-hiv-combo-therapy-210218-6061349/</loc>
		<lastmod>2018-07-04T15:20:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ad486monosol_rx_signs_licensing_agreement_with_hikma_pharmaceutic/</loc>
		<lastmod>2018-07-04T15:20:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c4b5lannett_wins_fda_approval_for_generic_act/</loc>
		<lastmod>2018-07-04T15:20:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sterna-biologicals-ulcerative-colitis-treatment-sb012-shows-significant-effect-in-secure-study-200218-6060767/</loc>
		<lastmod>2018-07-04T15:20:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b749bwatson_wins_fda_approval_for_generic_razadyne_er_cap/</loc>
		<lastmod>2018-07-04T15:20:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/064benymox_reports_new_encouraging_data_from_benign_prostatic_hyperplasia_/</loc>
		<lastmod>2018-07-04T15:20:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac4a8tongjitang_chinese_medicines_names_ne/</loc>
		<lastmod>2018-07-04T15:20:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bergenbio-completes-recruitment-into-first-stage-of-phase-ii-breast-cancer-trial-200218-6060466/</loc>
		<lastmod>2018-07-04T15:20:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dandrit-biotech-acquires-gene-therapy-company-enochian-biopharma-200218-6060341/</loc>
		<lastmod>2018-07-04T15:20:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9b496generex_and_pevion_sign_collaboration_agre/</loc>
		<lastmod>2018-07-04T15:20:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/044b1covance_acquires_equity_stake_in_caprion_proteom/</loc>
		<lastmod>2018-07-04T15:20:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0c4bfglobus_medical_names_ne/</loc>
		<lastmod>2018-07-04T15:20:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b4b2bioheart_to_spinoff_noncore_technology_pro/</loc>
		<lastmod>2018-07-04T15:20:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/174afchina_sky_one_medical_granted_production_rights_for_two_additional_dr/</loc>
		<lastmod>2018-07-04T15:20:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b4aballiance_imaging_acquires_shared_pet_imag/</loc>
		<lastmod>2018-07-04T15:20:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lillys-taltz-yields-positive-results-in-phase-3-genital-psoriasis-trial-190218-6060241/</loc>
		<lastmod>2018-07-04T15:20:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-cosentyx-improves-skin-clearance-in-scalp-psoriasis-study-190218-6059616/</loc>
		<lastmod>2018-07-04T15:20:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/424a1scolr_pharmas_ceo_re/</loc>
		<lastmod>2018-07-04T15:20:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seikagaku-begins-phase-3-us-trial-for-si-6603-for-lumbar-disc-herniation-190218-6059339/</loc>
		<lastmod>2018-07-04T15:20:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e4492fujirebio_and_roche_sign_licensing_and_supply_agreem/</loc>
		<lastmod>2018-07-04T15:20:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/164b7spacelabs_and_uscom_sign_distribution_agre/</loc>
		<lastmod>2018-07-04T15:20:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/80494epeius_biotech_granted_two_new_european_pa/</loc>
		<lastmod>2018-07-04T15:20:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8d4baethicon_introduces_new_hernia_d/</loc>
		<lastmod>2018-07-04T15:20:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/524b7jazz_pharmaceuticals_to_reduce_24_of_its_work/</loc>
		<lastmod>2018-07-04T15:20:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-launches-qvar-redihaler-inhalation-aerosol-in-us-190218-6059318/</loc>
		<lastmod>2018-07-04T15:20:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-imfinzi-wins-fda-approval-for-unresectable-stage-3-nsclc-190218-6058995/</loc>
		<lastmod>2018-07-04T15:20:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cancer-research-uk-to-spend-45m-on-cancer-clinical-trials-160218-6058202/</loc>
		<lastmod>2018-07-04T15:20:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca483osi_pharmaceuticals_names_new_evp_an/</loc>
		<lastmod>2018-07-04T15:20:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c54b1pioneer_surgical_technology_raises_15_million_in_fina/</loc>
		<lastmod>2018-07-04T15:20:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/59481epitomics_names_chief_scientific_of/</loc>
		<lastmod>2018-07-04T15:20:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-selumetinib-for-neurofibromatosis-type-1-160218-6057977/</loc>
		<lastmod>2018-07-04T15:20:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsks-fluarix-tetra-wins-european-approval-for-expanded-indication-160218-6057980/</loc>
		<lastmod>2018-07-04T15:20:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-to-buy-oncology-software-provider-flatiron-health-for-19bn-160218-6057744/</loc>
		<lastmod>2018-07-04T15:20:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1248axceleron_names_president_an/</loc>
		<lastmod>2018-07-04T15:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8e4banew_hospital_to_be_built_in_m/</loc>
		<lastmod>2018-07-04T15:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/veloxis-secures-60m-capital-from-athyrium-capital-150218-6056700/</loc>
		<lastmod>2018-07-04T15:21:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5b4a6nanoink_launches_new_div/</loc>
		<lastmod>2018-07-04T15:21:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astellas-acquires-universal-cells-for-102m-150218-6056564/</loc>
		<lastmod>2018-07-04T15:21:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssens-erleada-wins-fda-approval-for-certain-type-of-prostate-cancer-150218-6056387/</loc>
		<lastmod>2018-07-04T15:21:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d4a8lannett_introduces_two_new_pro/</loc>
		<lastmod>2018-07-04T15:21:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3m_licenses_cambridge_consultants_dry_powder_inhaler_technology_161208/</loc>
		<lastmod>2018-07-04T15:21:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristol_myers_and_exelixis_partner_in_cancer_drug_development_161208/</loc>
		<lastmod>2018-07-04T15:21:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristol_myers_squibb_reports_new_data_from_phase_iii_breast_cancer_studies_161208/</loc>
		<lastmod>2018-07-04T15:21:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lillys-radiographic-axial-spondyloarthritis-treatment-taltz-succeeds-in-phase-3-study-140218-6055377/</loc>
		<lastmod>2018-07-04T15:21:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bill-gates-foundation-awards-grants-to-mrna-vaccine-developer-curevac-140218-6055295/</loc>
		<lastmod>2018-07-04T15:21:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-secures-fda-approval-for-larger-dosage-of-ms-drug-glatopa-140218-6054965/</loc>
		<lastmod>2018-07-04T15:21:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dnar_presents_new_findings_from_breast_cancer_study_161208/</loc>
		<lastmod>2018-07-04T15:21:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lexicons_memory_drug_fails_endpoint_in_phase_iia_study_161208/</loc>
		<lastmod>2018-07-04T15:21:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ortho_biotech_reports_encouraging_results_from_phase_iii_breast_cancer_trial_161208/</loc>
		<lastmod>2018-07-04T15:21:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uks-nice-recommends-eusa-pharmas-fotivda-to-treat-advanced-renal-cell-carcinoma-130218-6054084/</loc>
		<lastmod>2018-07-04T15:21:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pacira_presents_positive_results_from_phase_ii_postoperative_pain_study_161208/</loc>
		<lastmod>2018-07-04T15:21:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/parkway_holdings_announces_cost_containment_measures_and_job_cuts_161208/</loc>
		<lastmod>2018-07-04T15:21:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/horizon-discovery-out-licenses-cell-line-engineering-technology-to-us-firm-130218-6053875/</loc>
		<lastmod>2018-07-04T15:21:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/phytopharm_terminates_collaboration_with_unilever_161208/</loc>
		<lastmod>2018-07-04T15:21:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche_wins_ce_mark_for_new_hiv_1_test_161208/</loc>
		<lastmod>2018-07-04T15:21:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vertexs-symdekotm-secures-fda-approval-for-cystic-fibrosis-130218-6053659/</loc>
		<lastmod>2018-07-04T15:21:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/santarus_forms_partnership_with_cosmo_technologies_161208/</loc>
		<lastmod>2018-07-04T15:21:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synta_obtains_15_million_milestone_payment_from_gsk_161208/</loc>
		<lastmod>2018-07-04T15:21:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vivus_initiates_phase_iii_erectile_dysfunction_trial_161208/</loc>
		<lastmod>2018-07-04T15:21:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roivant-poxel-to-develop-and-commercialise-imeglimin-in-us-europe-and-additional-countries-120218-6052848/</loc>
		<lastmod>2018-07-04T15:21:12+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->